<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id><journal-id journal-id-type="pmc-domain-id">48</journal-id><journal-id journal-id-type="pmc-domain">bmcneul</journal-id><journal-title-group><journal-title>BMC Neurology</journal-title></journal-title-group><issn pub-type="epub">1471-2377</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10426141</article-id><article-id pub-id-type="pmcid-ver">PMC10426141.1</article-id><article-id pub-id-type="pmcaid">10426141</article-id><article-id pub-id-type="pmcaiid">10426141</article-id><article-id pub-id-type="pmid">37582732</article-id><article-id pub-id-type="doi">10.1186/s12883-023-03284-6</article-id><article-id pub-id-type="publisher-id">3284</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Hossain</surname><given-names initials="I">Iftakher</given-names></name><address><email>ifthos@utu.fi</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Mohammadian</surname><given-names initials="M">Mehrbod</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Maanpää</surname><given-names initials="HR">Henna-Riikka</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Takala</surname><given-names initials="RSK">Riikka S. K.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tenovuo</surname><given-names initials="O">Olli</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van Gils</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hutchinson</surname><given-names initials="P">Peter</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Menon</surname><given-names initials="DK">David K.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Newcombe</surname><given-names initials="VF">Virginia F.</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tallus</surname><given-names initials="J">Jussi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hirvonen</surname><given-names initials="J">Jussi</given-names></name><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roine</surname><given-names initials="T">Timo</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kurki</surname><given-names initials="T">Timo</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Blennow</surname><given-names initials="K">Kaj</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zetterberg</surname><given-names initials="H">Henrik</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Posti</surname><given-names initials="JP">Jussi P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dbzj528</institution-id><institution-id institution-id-type="GRID">grid.410552.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 215X</institution-id><institution>Department of Neurosurgery, </institution><institution>Neurocenter, Turku University Hospital, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dbzj528</institution-id><institution-id institution-id-type="GRID">grid.410552.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 215X</institution-id><institution>Turku Brain Injury Center, Turku University Hospital, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05vghhr25</institution-id><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Department of Clinical Neurosciences, </institution><institution>University of Turku, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution>Department of Clinical Neurosciences, </institution><institution>Neurosurgery Unit, University of Cambridge, Addenbrooke’s Hospital, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dbzj528</institution-id><institution-id institution-id-type="GRID">grid.410552.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0628 215X</institution-id><institution>Intensive Care Medicine and Pain Management, </institution><institution>Perioperative Services, Turku University Hospital and University of Turku, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033003e23</institution-id><institution-id institution-id-type="GRID">grid.502801.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2314 6254</institution-id><institution>Faculty of Medicine and Health Technology, Tampere University, </institution></institution-wrap>Tampere, Finland </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution>Division of Anaesthesia, University of Cambridge, Addenbrooke’s Hospital, </institution></institution-wrap>Cambridge, UK </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Department of Radiology, </institution><institution>University of Turku and Turku University Hospital, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05vghhr25</institution-id><institution-id institution-id-type="GRID">grid.1374.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 1371</institution-id><institution>Turku Brain and Mind Center, University of Turku, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/020hwjq30</institution-id><institution-id institution-id-type="GRID">grid.5373.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0838 9418</institution-id><institution>Department of Neuroscience and Biomedical Engineering, </institution><institution>Aalto University School of Science, </institution></institution-wrap>Turku, Finland </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01tm6cn81</institution-id><institution-id institution-id-type="GRID">grid.8761.8</institution-id><institution-id institution-id-type="ISNI">0000 0000 9919 9582</institution-id><institution>Department of Psychiatry and Neurochemistry, </institution><institution>Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, </institution></institution-wrap>Mölndal, Sweden </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04vgqjj36</institution-id><institution-id institution-id-type="GRID">grid.1649.a</institution-id><institution-id institution-id-type="ISNI">0000 0000 9445 082X</institution-id><institution>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, </institution></institution-wrap>Mölndal, Sweden </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/048b34d51</institution-id><institution-id institution-id-type="GRID">grid.436283.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0612 2631</institution-id><institution>Department of Molecular Neuroscience, </institution><institution>UCL Institute of Neurology, Queen Square, </institution></institution-wrap>London, UK </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.83440.3b</institution-id><institution-id institution-id-type="ISNI">0000000121901201</institution-id><institution>UK Dementia Research Institute at UCL, University College London, </institution></institution-wrap>London, UK </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="GRID">grid.24515.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1450</institution-id><institution>Hong Kong Center for Neurodegenerative Diseases, </institution></institution-wrap>Hong Kong, China </aff></contrib-group><pub-date pub-type="epub"><day>15</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">425126</issue-id><elocation-id>304</elocation-id><history><date date-type="received"><day>25</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>16</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-12 02:25:13.840"><day>12</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>© The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12883_2023_Article_3284.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">It is known that blood levels of neurofilament light (NF-L) and diffusion-weighted magnetic resonance imaging (DW-MRI) are both associated with outcome of patients with mild traumatic brain injury (mTBI). Here, we sought to examine the association between admission levels of plasma NF-L and white matter (WM) integrity in post-acute stage DW-MRI in patients with mTBI.</p></sec><sec><title>Methods</title><p id="Par2">Ninety-three patients with mTBI (GCS ≥ 13), blood sample for NF-L within 24 h of admission, and DW-MRI ≥ 90 days post-injury (median = 229) were included. Mean fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD) were calculated from the skeletonized WM tracts of the whole brain. Outcome was assessed using the Extended Glasgow Outcome Scale (GOSE) at the time of imaging. Patients were divided into CT-positive and -negative, and complete (GOSE = 8) and incomplete recovery (GOSE &lt; 8) groups.</p></sec><sec><title>Results</title><p id="Par3">The levels of NF-L and FA correlated negatively in the whole cohort (<italic toggle="yes">p</italic> = 0.002), in CT-positive patients (<italic toggle="yes">p</italic> = 0.016), and in those with incomplete recovery (<italic toggle="yes">p</italic> = 0.005). The same groups showed a positive correlation with mean MD, AD, and RD (<italic toggle="yes">p</italic> &lt; 0.001—<italic toggle="yes">p</italic> = 0.011). In CT-negative patients or in patients with full recovery, significant correlations were not found.</p></sec><sec><title>Conclusion</title><p id="Par4">In patients with mTBI, the significant correlation between NF-L levels at admission and diffusion tensor imaging (DTI) measurements of diffuse axonal injury (DAI) over more than 3 months suggests that the early levels of plasma NF-L may associate with the presence of DAI at a later phase of TBI.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12883-023-03284-6.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Neurofilament light protein</kwd><kwd>Diffusion tensor imaging</kwd><kwd>Diffusion-weighted magnetic resonance imaging</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Finnish Medical Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Päivikki and Sakari Sohlberg Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Paulo Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Finnish Cultural Foundation</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>The Integra EANS Research Grant</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>University of Turku Graduate School funding</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>NIHR Research Professorship and the NIHR Cambridge BRC</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>NIHR Research UK (through a Senior Investigator Award and the Cambridge Biomedical Research Centre)</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Academy of Medical Sciences / The Health Foundation Clinician Scientist Fellowship</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>personal grants from Emil Aaltonen Foundation sr</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>grants from the Swedish Research Council and the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Wallenberg Scholarship and grants from the Swedish and European Research Councils</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002341</institution-id><institution>Academy of Finland</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Government’s Special Financial Transfer tied to academic research in Health Sciences (Finland)</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Maire Taponen Foundation sr</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Mild traumatic brain injury (mTBI), which includes concussion, accounts for 80% – 90% of all TBIs presenting to emergency departments [<xref ref-type="bibr" rid="CR1">1</xref>]. At a cellular level, the pathophysiology of mTBI consists primarily of diffuse injury caused by stretching and tearing of the brain tissue, followed by a complex cascade of neurometabolic changes [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. Diffuse axonal injury (DAI) is the main form of diffuse injury, and results from acceleration / deceleration forces leading to axonal shearing [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Computed tomography (CT), the most commonly used imaging method for acute TBI, is generally unable to detect DAI [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Also, conventional MRI is poor in showing or quantifying DAI, and neuropathological examination is the only accurate method for diagnosing DAI at the moment [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. Advanced neuroimaging methods, such as diffusion-weighted (DW) magnetic resonance (MR) imaging, have been shown to be sensitive enough to detect small abnormalities associated with DAI [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. Diffusion tensor imaging (DTI) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] is a technique to evaluate DAI in patients with mTBI in the subacute and chronic phases [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR20">20</xref>], but is still considered mainly as a research tool. Fractional anisotropy (FA) and mean diffusivity (MD) have been the main focus in DTI studies after an mTBI [<xref ref-type="bibr" rid="CR20">20</xref>]. DW-MRI based structural connectivity after mTBI has been recently shown to be related to outcome [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par6">Regrettably, biomarkers to assess the degree of axonal injury or the multidimensional pathophysiological events following mTBI are not yet available for clinical use [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Neurofilament light (NF-L) protein is an axonal biomarker that can be measured in blood samples with ultrasensitive Single molecule array (Simoa) technology [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. NF-L is mainly expressed in the long myelinated WM axons [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. A significant association between DTI measures of DAI and the serum levels of NF-L following severe TBI (sTBI) has been reported, suggesting that the levels of NF-L may reflect the degree of axonal injury [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Elevated levels of plasma NF-L in mTBI have been found in contact sports athletes, although those studies did not report the correlation between the levels of NF-L and WM integrity [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. Recently, a significant association between the early plasma levels of NF-L and the outcome in patients with mTBI has been reported in a prospectively collected well-characterized cohort by our research group [<xref ref-type="bibr" rid="CR31">31</xref>], which supports the concept that NF-L is a potential blood biomarker to explore the complex pathophysiology of axonal injury following mTBI. A recent study by Shahim et al. examined the time course and diagnostic utility of NF-L in subacute and chronic TBI, demonstrating that increased serum concentrations of NF-L at enrolment correlated with the DTI measures of DAI [<xref ref-type="bibr" rid="CR32">32</xref>]. Another multicenter prospective study also reported that the levels of plasma NF-L reflect the WM damage following TBI [<xref ref-type="bibr" rid="CR33">33</xref>]. A recent pilot study on the adolescent soccer players also reported a significant association between DTI metrics and proteomic blood biomarkers, including NF-L [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par7">Since it is known that blood levels of NF-L and DW-MRI are both associated with outcome of patients with mTBI, we sought to investigate the possible association between the admission levels of plasma NF-L and WM integrity, measured using post-acute DTI metrics. The hypothesis of this study is that acute level of plasma NF-L following mTBI may help clinicians better stratify those patients who require further DTI imaging to understand acquired axonal injury.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study population</title><p id="Par8">This prospective study was part of the EU-funded TBIcare (Evidence-based Diagnostic and Treatment Planning Solution for Traumatic Brain Injuries) project. From November 2011 to October 2013, 93 patients with mTBI [Glasgow Coma Scale (GCS) ≥ 13] and a control group of 21patients with orthopedic injury (OI) were recruited, with blood samples available within 24 h from the arrival to the emergency department (ED) of the Turku University Hospital, Finland.</p><p id="Par9">The inclusion criteria for patients with mTBI were: lowest GCS ≥ 13, age ≥ 18 years, clinical diagnosis of TBI, and indications for acute head CT according to NICE criteria (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nice.org.uk/guidance/cg176">http://www.nice.org.uk/guidance/cg176</ext-link>). The exclusion criteria were: age &lt; 18 years, blast-induced or penetrating injury, chronic subdural hematoma, inability to live independently due to pre-existing brain disease, admission more than 2 weeks from the injury, not living in the district (thereby preventing follow-up visits), not speaking native language, or no consent received.</p><p id="Par10">The inclusion criteria for patients with OI were: age ≥ 18 years, acute nontrivial OI, no concomitant TBI, and no CNS involvement. The exclusion criteria were: any suspicion of concomitant acute TBI, history of any brain disease or TBI, need for admission to intensive care due to polytrauma, or trivial injuries with no necessity for emergency measures or follow-up.</p></sec><sec id="Sec4"><title>Analysis of NF-L</title><p id="Par11">Although majority of the samples were obtained within 24 h of admission, they were not always drawn within 24 h after injury. All samples were kept in cold ice and processed within 1 h and stored at − 80 °C until analysis. At the day of the measurements, samples are thawed and kept on ice until diluted into sample diluent according to the protocol provided in the kit insert. NF-L is a stable analyte that is not sensitive to storage temperature or repeated freezing–thawing [<xref ref-type="bibr" rid="CR35">35</xref>]. Plasma NF-L levels were measured using the Human Neurology 4-Plex A assay on an HD-1 Simoa instrument according to instructions from the manufacturer (Quanterix, Billerica, MA). The measurements were performed in one round of experiments using one batch of reagents by board-certified laboratory technicians who were blinded to clinical data. Quality control (QC) samples were analyzed in each run, with coefficients of variations of 4.4% at 13.9 pg/mL and 6.1% at 7.1 pg/mL for NF-L. The lower limit of detection (LLoD) and the lower limit of quantification (LloQ) for NF-L were 0.104 pg/mL and 0.241 pg/mL, respectively and a calibration range between 0.533 pg/mL and 453.0 pg/mL.</p></sec><sec id="Sec5"><title>TBI severity and outcome grading</title><p id="Par12">For the assessment of TBI severity, the lowest recorded GCS assessed by paramedics at the scene of accident or during transport, and / or by an emergency physician at the time of admission was used[<xref ref-type="bibr" rid="CR31">31</xref>]. The overall injury severity of the patients was assessed using the Injury Severity Score (ISS) [<xref ref-type="bibr" rid="CR36">36</xref>]. The descriptive system proposed by Marshall et al. was used to classify the CT scans, where class 1 corresponds with normal CT, classes 2 – 4 with diffuse injuries, and classes 5 – 6 CTs with mass lesions [<xref ref-type="bibr" rid="CR37">37</xref>]. Patients were divided into CT-positive and -negative groups based on presence or absence of intra-cranial injury.</p></sec><sec id="Sec6"><title>Outcome</title><p id="Par13">The outcome was assessed between 4 – 16 months from the injury using the Extended Glasgow Outcome Score (GOSE), and in close proximity (same day or within a few days) to the DTI scan [<xref ref-type="bibr" rid="CR38">38</xref>]. Outcomes were dichotomized to complete recovery (GOSE = 8), or incomplete recovery (GOSE &lt; 8). Every patient was evaluated by the same experienced neurologist at the Turku University Hospital.</p></sec><sec id="Sec7"><title>MRI acquisition</title><p id="Par14">The MRIs were acquired at Turku University Hospital with a Siemens Verio 3 T scanner. Fluid attenuated inversion recovery, Susceptibility-Weighted imaging, T2-weighted, and DW-MR images were obtained from each subject. DW-MRI utilizing spin-echo, echo-planar imaging was obtained using the following parameters: TR 11.7 s, TE 106 ms, voxel size of 2 × 2 × 2 mm. Diffusion gradients were applied in 64 directions with a b-value of 1000 s/mm<sup>2</sup>. FA and MD of DW-MRI were used as indicators of WM integrity at a later stage. However, axial diffusivity (AD) and radial diffusivity (RD) metrics were also taken into consideration.</p></sec><sec id="Sec8"><title>DTI analyses</title><p id="Par15">DW-MR images were corrected for subject’s motion, eddy current, and EPI distortions [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Tensors were then fitted in each voxel and anisotropy and diffusivity maps were calculated using the ExploreDTI tool [<xref ref-type="bibr" rid="CR41">41</xref>]. ExploreDTI was used to perform the pre-processing of the DW-MR images as images with reverse phase encoding were not acquired in this study and the tensor estimation was done in ExploreDTI to avoid probable errors in flipping of gradient orientations. FA, MD, AD, and RD maps were then fed into FMRIB Software Library (FSL). After data were pre-processed, FA images from each subject were non-linearly aligned to the FAMRIB_FA template in MNI space and were projected to a skeletonized mean FA image using tract-based spatial statistics [<xref ref-type="bibr" rid="CR42">42</xref>]. Similarly, MD, AD, and RD images were projected to the WM skeleton using the non-linear warps and skeleton projection performed in the previous step for FA images. Mean DTI metrics values were then calculated from the whole skeletonized WM tracts of the whole brain.</p></sec><sec id="Sec9"><title>Statistical analyses</title><p id="Par16">All statistical analyses were performed in IBM SPSS (Version 24, Armonk, NY, USA) and MATLAB (R2018b, Natick, MA, USA). Normality of the variables were assessed using Shapiro–Wilk test and histogram analysis. Non-parametric Mann–Whitney U test was used to compare the levels of NF-L between patient groups. Generalized linear modelling, with age and sex as covariates, was performed to assess the difference in WM microstructural properties between patient groups. Correlations between the levels of NF-L and DTI metrics (FA, MD, AD, and RD) in different patient groups/subgroups were analyzed with (partial) Spearman’s rank correlation coefficient (ρ) accounting for age and sex. The above-mentioned methods were also utilized to compare the levels of NF-L between patients with mTBI and patients with OI. A confidence interval of 95% was used to specify the significance of the results.</p></sec></sec><sec id="Sec10"><title>Results</title><p id="Par17">Patient characteristics are described in detail in Table <xref rid="Tab1" ref-type="table">1</xref>. Ninety-three patients with mTBI were dichotomized to overlapping radiological and clinical outcome groups of CT-positive (<italic toggle="yes">n</italic> = 40, 43.0%) or CT-negative (<italic toggle="yes">n</italic> = 53, 57%), and with complete (<italic toggle="yes">n</italic> = 35, 37.6%) or incomplete (<italic toggle="yes">n</italic> = 58, 62.4%) recovery. We also performed a separate analysis on CT-negative patients with complete (<italic toggle="yes">n</italic> = 29, 54.7%) or incomplete (<italic toggle="yes">n</italic> = 24, 45.3%) recovery.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Patient Demographics and Clinical Characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">All mTBI</th><th align="left" colspan="1" rowspan="1">CT-negative</th><th align="left" colspan="1" rowspan="1">CT-positive</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">Complete recovery</th><th align="left" colspan="1" rowspan="1">Incomplete recovery</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">OI controls</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">No. of patients (%)</td><td align="left" colspan="1" rowspan="1">93*</td><td align="left" colspan="1" rowspan="1">53* (57.0)</td><td align="left" colspan="1" rowspan="1">40 (43.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">35*</td><td align="left" colspan="1" rowspan="1">58*</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">21</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Years of Age</td><td align="left" colspan="1" rowspan="1">0.111 <sup>a</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.791<sup>a</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.870<sup>a</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> Median (IQR)</td><td align="left" colspan="1" rowspan="1">47.00 (36)</td><td align="left" colspan="1" rowspan="1">46.0 (34)</td><td align="left" colspan="1" rowspan="1">52.00 (43)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">47.00 (44)</td><td align="left" colspan="1" rowspan="1">47.00 (31)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">43 (29)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Mean (SD)</td><td align="left" colspan="1" rowspan="1">45.99 (19.59)</td><td align="left" colspan="1" rowspan="1">43.17 (18.4)</td><td align="left" colspan="1" rowspan="1">49.73 (20.72) (20.72)(20.72)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">45.26 (21.91)</td><td align="left" colspan="1" rowspan="1">46.43 (18.24)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">45.24 (16.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Sex n (%)</td><td align="left" colspan="1" rowspan="1">0.043 <sup>b</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.178<sup>b</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.305<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> Male</td><td align="left" colspan="1" rowspan="1">64 (68.8)</td><td align="left" colspan="1" rowspan="1">32 (60.4)</td><td align="left" colspan="1" rowspan="1">32 (80.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">27 (77.1)</td><td align="left" colspan="1" rowspan="1">37 (63.8)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">12 (57.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Female</td><td align="left" colspan="1" rowspan="1">29 (31.2)</td><td align="left" colspan="1" rowspan="1">21 (39.6)</td><td align="left" colspan="1" rowspan="1">8 (20.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">8 (22.9)</td><td align="left" colspan="1" rowspan="1">21 (36.3)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">9 (42.9)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Worst GCS n (%)</td><td align="left" colspan="1" rowspan="1">0.106 <sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.775<sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.004<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> 15</td><td align="left" colspan="1" rowspan="1">62 (66.7)</td><td align="left" colspan="1" rowspan="1">40 (75.5)</td><td align="left" colspan="1" rowspan="1">22 (55.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">22 (62.))</td><td align="left" colspan="1" rowspan="1">40 (69.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">21 (100)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 14</td><td align="left" colspan="1" rowspan="1">25 (26.9)</td><td align="left" colspan="1" rowspan="1">10 (18.9)</td><td align="left" colspan="1" rowspan="1">15 (37.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">11 (31.4)</td><td align="left" colspan="1" rowspan="1">14 (24.1)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 13</td><td align="left" colspan="1" rowspan="1">6 (6.5)</td><td align="left" colspan="1" rowspan="1">3 (5.7)</td><td align="left" colspan="1" rowspan="1">3 (7.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2 (5.7)</td><td align="left" colspan="1" rowspan="1">4 (6.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Cause of injury n (%)</td><td align="left" colspan="1" rowspan="1">0.031 <sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.399<sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.057<sup>c</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> Road traffic crash</td><td align="left" colspan="1" rowspan="1">28 (30.1)</td><td align="left" colspan="1" rowspan="1">17 (32.1)</td><td align="left" colspan="1" rowspan="1">11 (27.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">7 (20.0)</td><td align="left" colspan="1" rowspan="1">21 (36.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4 (19.0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Incidental fall</td><td align="left" colspan="1" rowspan="1">49 (52.7)</td><td align="left" colspan="1" rowspan="1">22 (41.5)</td><td align="left" colspan="1" rowspan="1">27 (67.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">22 (62.9)</td><td align="left" colspan="1" rowspan="1">27 (46.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">12 (57.1)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Violence/assault</td><td align="left" colspan="1" rowspan="1">9 (9.7)</td><td align="left" colspan="1" rowspan="1">8 (15.1)</td><td align="left" colspan="1" rowspan="1">1 (2.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4 (11.4)</td><td align="left" colspan="1" rowspan="1">5 (8.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Other non-intentional injury</td><td align="left" colspan="1" rowspan="1">4 (4.3)</td><td align="left" colspan="1" rowspan="1">4 (7.5)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2 (5.7)</td><td align="left" colspan="1" rowspan="1">2 (3.4)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">5 (23.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Suicide attempt</td><td align="left" colspan="1" rowspan="1">1 (1.1)</td><td align="left" colspan="1" rowspan="1">1 (1.9)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">1 (1.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Other</td><td align="left" colspan="1" rowspan="1">2 (2.2)</td><td align="left" colspan="1" rowspan="1">1 (1.9)</td><td align="left" colspan="1" rowspan="1">1 (2.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (3.4)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Isolated TBI n (%)</td><td align="left" colspan="1" rowspan="1">51 (54.8)</td><td align="left" colspan="1" rowspan="1">32 (60.4)</td><td align="left" colspan="1" rowspan="1">19 (47.5)</td><td align="left" rowspan="2" colspan="1">0.217 <sup>b</sup></td><td align="left" colspan="1" rowspan="1">22 (62.9)</td><td align="left" colspan="1" rowspan="1">29 (50.0)</td><td align="left" rowspan="2" colspan="1">0.227<sup>b</sup></td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"> Extracranial injuries with TBI n (%)</td><td align="left" colspan="1" rowspan="1">42 (45.2)</td><td align="left" colspan="1" rowspan="1">21 (39.6)</td><td align="left" colspan="1" rowspan="1">21 (52.5)</td><td align="left" colspan="1" rowspan="1">13 (37.1)</td><td align="left" colspan="1" rowspan="1">29 (50.0)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="7" rowspan="1">CT findings (Marshall Grade), n (%)</td><td align="left" colspan="1" rowspan="1">0.333<sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"> Diffuse injury I, no visual pathology</td><td align="left" colspan="1" rowspan="1">53 (57.0)</td><td align="left" colspan="1" rowspan="1">53 (100)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">24 (68.6)</td><td align="left" colspan="1" rowspan="1">29 (50.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Diffuse injury II</td><td align="left" colspan="1" rowspan="1">25 (26.9)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">25 (62.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">8 (22.9)</td><td align="left" colspan="1" rowspan="1">17 (29.3)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Diffuse injury III</td><td align="left" colspan="1" rowspan="1">3 (3.2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (7.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">3 (5.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Diffuse injury IV</td><td align="left" colspan="1" rowspan="1">2 (2.2)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">2 (5.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">1 (2.9)</td><td align="left" colspan="1" rowspan="1">1 (1.7)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Evacuated mass lesions</td><td align="left" colspan="1" rowspan="1">6 (6.5)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">6 (15.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2 (5.7)</td><td align="left" colspan="1" rowspan="1">4 (6.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Non-evacuated mass lesions</td><td align="left" colspan="1" rowspan="1">4 (4.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (10.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (6.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">GOSE n (%)</td><td align="left" colspan="1" rowspan="1">0.086<sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.000<sup>c</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"> 8</td><td align="left" colspan="1" rowspan="1">35 (37.6)</td><td align="left" colspan="1" rowspan="1">24 (45.3)</td><td align="left" colspan="1" rowspan="1">11 (27.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">35 (100)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 7</td><td align="left" colspan="1" rowspan="1">32 (34.4)</td><td align="left" colspan="1" rowspan="1">16 (30.2)</td><td align="left" colspan="1" rowspan="1">16 (40.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">32 (55.2)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 6</td><td align="left" colspan="1" rowspan="1">13 (14.0)</td><td align="left" colspan="1" rowspan="1">9 (17.0)</td><td align="left" colspan="1" rowspan="1">4 (10.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">13 (22.4)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 5</td><td align="left" colspan="1" rowspan="1">4 (4.3)</td><td align="left" colspan="1" rowspan="1">2 (3.8)</td><td align="left" colspan="1" rowspan="1">2 (5.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4 (6.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 4</td><td align="left" colspan="1" rowspan="1">5 (5.4)</td><td align="left" colspan="1" rowspan="1">2 (3.8)</td><td align="left" colspan="1" rowspan="1">3 (7.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">5 (8.6)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> 3</td><td align="left" colspan="1" rowspan="1">4 (4.3)</td><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">4 (10.0)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4 (6.9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="4" rowspan="1">Injury Severity Score</td><td align="left" colspan="1" rowspan="1">0.001<sup>d</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.037<sup>d</sup></td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">0.001<sup>d</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> Median (IQR)</td><td align="left" colspan="1" rowspan="1">11.00 (15)</td><td align="left" colspan="1" rowspan="1">6.00 (11)</td><td align="left" colspan="1" rowspan="1">13.50 (9)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">6.00 (12.00)</td><td align="left" colspan="1" rowspan="1">11.00 (13.00)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4.00 (0)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Mean (SD)</td><td align="left" colspan="1" rowspan="1">12.12 (9.88)</td><td align="left" colspan="1" rowspan="1">9.55 (9.218)</td><td align="left" colspan="1" rowspan="1">15.40 (0.83)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">9.56 (9.05)</td><td align="left" colspan="1" rowspan="1">13.65 (10.11)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">4.57 (2.89)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"> Admitted to hospital</td><td align="left" colspan="1" rowspan="1">68 (73.1)</td><td align="left" colspan="1" rowspan="1">32 (60.4)</td><td align="left" colspan="1" rowspan="1">36 (90.0)</td><td align="left" rowspan="2" colspan="1">0.001<sup>b</sup></td><td align="left" colspan="1" rowspan="1">24 (31.4)</td><td align="left" colspan="1" rowspan="1">44 (75.9)</td><td align="left" rowspan="2" colspan="1">0.442<sup>b</sup></td><td align="left" colspan="1" rowspan="1">17 (81.0)</td><td align="left" colspan="1" rowspan="1">0.457<sup>b</sup></td></tr><tr><td align="left" colspan="1" rowspan="1"> Discharged from the emergency department</td><td align="left" colspan="1" rowspan="1">25 (26.9)</td><td align="left" colspan="1" rowspan="1">21 (39.6)</td><td align="left" colspan="1" rowspan="1">4 (10.0)</td><td align="left" colspan="1" rowspan="1">11 (68.6)</td><td align="left" colspan="1" rowspan="1">14 (24.1)</td><td align="left" colspan="1" rowspan="1">4 (19.0)</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p>Computed tomography negative (CT-negative) = Marshall 1, Computed tomography positive (CT-positive) = Marshall 2–6. Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery</p><p>*For the injury severity score (ISS), there was no information available for 2 patients in the TBI cohort</p><p><sup>a</sup>Independent samples T-test</p><p><sup>b</sup>Chi-Square</p><p><sup>c</sup>Fisher's Exact Test and</p><p><sup>d</sup>Mann–Whitney U-test all with 0.05 significance level</p></table-wrap-foot></table-wrap></p><p id="Par18">The majority (<italic toggle="yes">n</italic> = 80, 86.5%) of the blood samples from mTBI patients was obtained within 24 h of the hospital admission. The exact injury time was available for 60.2% (<italic toggle="yes">n</italic> = 56) of the subjects with a median time elapse from injury to blood sampling of 11 h (IQR = 13.8). Among patients for whom the exact injury time was unavailable, 8 patients were sampled within 24 h and 29 patients were sampled after 24 h from the injury. DW-MRI was obtained 126 – 429 days after the injury (median = 229, IQR = 71). Injury severity score (ISS) was higher in the CT-positive group (median = 13.5, IQR = 9) than in the CT-negative group (median = 6, IQR = 11, <italic toggle="yes">p</italic> = 0.001). Further, differences were found between patients with complete recovery (median = 6, IQR = 12) and incomplete recovery (median = 11, IQR = 13, <italic toggle="yes">p</italic> = 0.037). There was a male predominance in the whole mTBI cohort, but this was even more pronounced in the CT-positive group (80.0%, <italic toggle="yes">p</italic> = 0.043).</p><sec id="Sec11"><title>Differences in DTI metrics in patients with mTBI</title><p id="Par19">The results for DTI metrics are presented in Fig. <xref rid="Fig1" ref-type="fig">1</xref> and Table <xref rid="Tab2" ref-type="table">2</xref>. FA values were higher in CT- negative patients (mean = 0.423, SD = 0.023) than in CT-positive patients (mean = 0.401, SD = 0.025) (<italic toggle="yes">p</italic> &lt; 0.001). MD levels were higher in the CT-positive subgroup (mean = 0.827, SD = 0.073) than in the CT-negative subgroup (mean = 0.78, SD = 0.046) (<italic toggle="yes">p</italic> = 0.004). AD in the CT-positive subgroup (mean = 1.15, SD = 0.063) was higher than in the CT-negative subgroup (mean = 1.12, SD = 0.04) (<italic toggle="yes">p</italic> = 0.021). RD was also higher in the CT-positive subgroup (mean = 0.666, SD = 0.081) than in the CT-negative subgroup (mean = 0.612, SD = 0.055) (<italic toggle="yes">p</italic> = 0.002). Between the subgroups of complete and incomplete recovery, there were no differences in the various DTI metrics (Table <xref rid="Tab2" ref-type="table">2</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Diffusion tensor imaging (DTI) metrics values for the different mild traumatic brain injury (mTBI) subgroups. Computed tomography positive = CT-positive, computed tomography negative = CT-negative, Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, and Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery. FA = fractional anisotropy, MD = mean diffusivity, AD = axial diffusivity, RD = radial diffusivity</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12883_2023_3284_Fig1_HTML.jpg"/></fig><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Comparison of neurofilament light levels between mild traumatic brain injury patients and orthopedic injury controls. The comparison between the diffusion metrics of the mTBI subgroup</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">NF-L levels</th><th align="left" colspan="2" rowspan="1">FA</th><th align="left" colspan="2" rowspan="1">MD (× 10<sup>–3</sup>)</th><th align="left" colspan="2" rowspan="1">AD (× 10<sup>–3</sup>)</th><th align="left" colspan="2" rowspan="1">RD (× 10<sup>–3</sup>)</th></tr><tr><th align="left" colspan="1" rowspan="1">Group</th><th align="left" colspan="1" rowspan="1">median [IQR]</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value<sup>a</sup></th><th align="left" colspan="1" rowspan="1">mean [SD]</th><th align="left" colspan="1" rowspan="1">p-value<sup>b</sup></th><th align="left" colspan="1" rowspan="1">mean [SD]</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value<sup>b</sup></th><th align="left" colspan="1" rowspan="1">mean [SD]</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value<sup>b</sup></th><th align="left" colspan="1" rowspan="1">mean [SD]</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value<sup>b</sup></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">all mTBI</td><td align="left" colspan="1" rowspan="1">14.28 [27.32]</td><td char="." align="char" colspan="1" rowspan="1">0.038</td><td align="left" colspan="1" rowspan="1">0.414 [0.026]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.8 [0.064]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">1.13 [0.053]</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.635 [0.072]</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Negative</td><td align="left" colspan="1" rowspan="1">10.42 [8.3]</td><td char="." align="char" colspan="1" rowspan="1">0.890</td><td align="left" colspan="1" rowspan="1">0.423 [0.023]</td><td align="left" rowspan="2" colspan="1"><italic toggle="yes">p</italic> &lt; 0.001</td><td align="left" colspan="1" rowspan="1">0.78 [0.046]</td><td align="left" rowspan="2" colspan="1">0.004</td><td align="left" colspan="1" rowspan="1">1.12 [0.04]</td><td align="left" rowspan="2" colspan="1">0.021</td><td align="left" colspan="1" rowspan="1">0.612 [0.055]</td><td align="left" rowspan="2" colspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Positive</td><td align="left" colspan="1" rowspan="1">31.37 [48.54]</td><td char="." align="char" colspan="1" rowspan="1"><italic toggle="yes">p</italic> &lt; 0.001</td><td align="left" colspan="1" rowspan="1">0.401 [0.025]</td><td align="left" colspan="1" rowspan="1">0.827 [0.073]</td><td align="left" colspan="1" rowspan="1">1.15 [0.063]</td><td align="left" colspan="1" rowspan="1">0.666 [0.081]</td></tr><tr><td align="left" colspan="1" rowspan="1">Complete recovery</td><td align="left" colspan="1" rowspan="1">11.16 [10.68]</td><td char="." align="char" colspan="1" rowspan="1">0.383</td><td align="left" colspan="1" rowspan="1">0.417 [0.022]</td><td align="left" rowspan="2" colspan="1">0.145</td><td align="left" colspan="1" rowspan="1">0.792 [0.049]</td><td align="left" rowspan="2" colspan="1">0.19</td><td align="left" colspan="1" rowspan="1">1.12 [0.44]</td><td align="left" rowspan="2" colspan="1">0.291</td><td align="left" colspan="1" rowspan="1">0.625 [0.058]</td><td align="left" rowspan="2" colspan="1">0.171</td></tr><tr><td align="left" colspan="1" rowspan="1">Incomplete recovery</td><td align="left" colspan="1" rowspan="1">16.22 [40.97]</td><td char="." align="char" colspan="1" rowspan="1">0.01</td><td align="left" colspan="1" rowspan="1">0.411 [0.028]</td><td align="left" colspan="1" rowspan="1">0.8 [0.071]</td><td align="left" colspan="1" rowspan="1">1.13 [0.059]</td><td align="left" colspan="1" rowspan="1">0.641 [0.08]</td></tr><tr><td align="left" colspan="1" rowspan="1">Orthopedic Injury Controls</td><td align="left" colspan="1" rowspan="1">10.8 [6.8]</td><td char="." align="char" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Mann-Whitney U test, <italic toggle="yes">p</italic>-values show the difference between Orthopedic Injury Controls and the patient groups</p><p><sup>b</sup>Generalized linear model where age and sex are used as confounders, <italic toggle="yes">p</italic>-values represent the comparison between patient groups only</p><p><italic toggle="yes">mTBI</italic> mild traumatic brain injury, <italic toggle="yes">CT</italic> Computed tomography, <italic toggle="yes">NF-L</italic> Neurofilament light, <italic toggle="yes">FA</italic> Fractional anisotropy, <italic toggle="yes">MD</italic> Mean diffusivity, <italic toggle="yes">AD</italic> Axial diffusivity, <italic toggle="yes">RD</italic> Radial diffusivity, <italic toggle="yes">IQR</italic> Interquartile range, <italic toggle="yes">SD</italic> Standard deviation</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec12"><title>Correlation between NF-L levels and DTI metrics in patients with mTBI</title><p id="Par20">A negative correlation was observed between the level of NF-L and FA in the whole mTBI group (ρ = -0.323, <italic toggle="yes">p</italic> = 0.002), in CT-positive patients (<italic toggle="yes">ρ</italic> = -0.389, p = 0.016) and in patients with incomplete recovery (<italic toggle="yes">ρ</italic> = -0.367, <italic toggle="yes">p</italic> = 0.005) (Table <xref rid="Tab3" ref-type="table">3</xref>). In the complete recovery or CT-negative subgroups, no correlation was observed (Table <xref rid="Tab3" ref-type="table">3</xref>). No correlation was detected in CT-negative patients with incomplete or complete recovery, either (Table <xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Correlation between admission neurofilament light (NF-L) levels and diffusion measures (adjusted for age and sex)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1"/><th align="left" colspan="2" rowspan="1">FA</th><th align="left" colspan="2" rowspan="1">MD</th><th align="left" colspan="2" rowspan="1">AD</th><th align="left" colspan="2" rowspan="1">RD</th></tr><tr><th align="left" colspan="1" rowspan="1">Group</th><th align="left" colspan="1" rowspan="1">Number of patients</th><th align="left" colspan="1" rowspan="1">Spearman’s rho</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">Spearman’s rho</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">Spearman’s rho</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th><th align="left" colspan="1" rowspan="1">Spearman’s rho</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">all mTBI</td><td align="left" colspan="1" rowspan="1">93</td><td align="left" colspan="1" rowspan="1">-0.323</td><td char="." align="char" colspan="1" rowspan="1">0.002</td><td char="." align="char" colspan="1" rowspan="1">0.343</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> &lt; 0.001</td><td char="." align="char" colspan="1" rowspan="1">0.313</td><td char="." align="char" colspan="1" rowspan="1">0.003</td><td char="." align="char" colspan="1" rowspan="1">0.324</td><td char="." align="char" colspan="1" rowspan="1">0.002</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Negative</td><td align="left" colspan="1" rowspan="1">53</td><td align="left" colspan="1" rowspan="1">-0.032</td><td char="." align="char" colspan="1" rowspan="1">0.825</td><td char="." align="char" colspan="1" rowspan="1">0.194</td><td align="left" colspan="1" rowspan="1">0.172</td><td char="." align="char" colspan="1" rowspan="1">0.214</td><td char="." align="char" colspan="1" rowspan="1">0.132</td><td char="." align="char" colspan="1" rowspan="1">0.163</td><td char="." align="char" colspan="1" rowspan="1">0.252</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Positive</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">-0.389</td><td char="." align="char" colspan="1" rowspan="1">0.016</td><td char="." align="char" colspan="1" rowspan="1">0.408</td><td align="left" colspan="1" rowspan="1">0.011</td><td char="." align="char" colspan="1" rowspan="1">0.453</td><td char="." align="char" colspan="1" rowspan="1">0.004</td><td char="." align="char" colspan="1" rowspan="1">0.4</td><td char="." align="char" colspan="1" rowspan="1">0.013</td></tr><tr><td align="left" colspan="1" rowspan="1">Complete recovery</td><td align="left" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">-0.184</td><td char="." align="char" colspan="1" rowspan="1">0.306</td><td char="." align="char" colspan="1" rowspan="1">0.182</td><td align="left" colspan="1" rowspan="1">0.311</td><td char="." align="char" colspan="1" rowspan="1">0.044</td><td char="." align="char" colspan="1" rowspan="1">0.808</td><td char="." align="char" colspan="1" rowspan="1">0.179</td><td char="." align="char" colspan="1" rowspan="1">0.318</td></tr><tr><td align="left" colspan="1" rowspan="1">Incomplete recovery</td><td align="left" colspan="1" rowspan="1">58</td><td align="left" colspan="1" rowspan="1">-0.367</td><td char="." align="char" colspan="1" rowspan="1">0.005</td><td char="." align="char" colspan="1" rowspan="1">0.395</td><td align="left" colspan="1" rowspan="1">0.003</td><td char="." align="char" colspan="1" rowspan="1">0.394</td><td char="." align="char" colspan="1" rowspan="1">0.003</td><td char="." align="char" colspan="1" rowspan="1">0.35</td><td char="." align="char" colspan="1" rowspan="1">0.008</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Negative with complete recovery</td><td align="left" colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">-0.131</td><td char="." align="char" colspan="1" rowspan="1">0.562</td><td char="." align="char" colspan="1" rowspan="1">0.22</td><td align="left" colspan="1" rowspan="1">0.325</td><td char="." align="char" colspan="1" rowspan="1">0.131</td><td char="." align="char" colspan="1" rowspan="1">0.561</td><td char="." align="char" colspan="1" rowspan="1">0.223</td><td char="." align="char" colspan="1" rowspan="1">0.318</td></tr><tr><td align="left" colspan="1" rowspan="1">CT-Negative with incomplete recovery</td><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">0.032</td><td char="." align="char" colspan="1" rowspan="1">0.873</td><td char="." align="char" colspan="1" rowspan="1">0.078</td><td align="left" colspan="1" rowspan="1">0.699</td><td char="." align="char" colspan="1" rowspan="1">0.216</td><td char="." align="char" colspan="1" rowspan="1">0.278</td><td char="." align="char" colspan="1" rowspan="1">0.060</td><td char="." align="char" colspan="1" rowspan="1">0.766</td></tr></tbody></table><table-wrap-foot><p>Computed tomography negative (CT-negative) = Marshall 1, Computed tomography positive (CT-positive) = Marshall 2–6. Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery. <italic toggle="yes">FA</italic> Fractional anisotropy, <italic toggle="yes">MD</italic> Mean diffusivity, <italic toggle="yes">AD</italic> Axial diffusivity, <italic toggle="yes">RD</italic> Radial diffusivity</p></table-wrap-foot></table-wrap></p><p id="Par21">A positive correlation was observed between the levels of NF-L and MD in the whole mTBI cohort (<italic toggle="yes">ρ</italic> = 0.343, <italic toggle="yes">p</italic> &lt; 0.001), in CT-positive patients (<italic toggle="yes">ρ</italic> = 0.408, <italic toggle="yes">p</italic> = 0.011), and in patients with incomplete recovery (<italic toggle="yes">ρ</italic> = 0.395, <italic toggle="yes">p</italic> = 0.003) (Table <xref rid="Tab3" ref-type="table">3</xref>). No correlations were observed in the subgroups of all CT-negative patients, in all patients with complete recovery, or in CT-negative patients with incomplete or complete recovery (Table <xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par22">The levels of NF-L showed a positive correlation with AD in all patients with mTBI (<italic toggle="yes">ρ</italic> = 0.313, p = 0.003) (Table <xref rid="Tab3" ref-type="table">3</xref>). The subgroup analysis revealed a positive correlation also in CT-positive patients (ρ = 0.453, <italic toggle="yes">p</italic> = 0.004), and in patients with incomplete recovery (<italic toggle="yes">ρ</italic> = 0.394, <italic toggle="yes">p</italic> = 0.003), but no correlation was found between NF-L levels and AD in patients with complete recovery or in the CT-negative patients (Table <xref rid="Tab3" ref-type="table">3</xref>). Again, no correlation was observed in CT-negative patients with either incomplete or complete recovery (Table <xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par23">Like other diffusivity measures, RD was positively correlated with NF-L levels in all patients with mTBI (<italic toggle="yes">ρ</italic> = 0.324, <italic toggle="yes">p</italic> = 0.002), as well as in CT-positive (<italic toggle="yes">ρ</italic> = 0.4, <italic toggle="yes">p</italic> = 0.013) and incomplete recovery (<italic toggle="yes">ρ</italic> = 0.35, <italic toggle="yes">p</italic> = 0.008) groups, but not in patients with complete recovery, in CT-negative patients, or in the subgroups of CT-negative patients with incomplete or complete recovery (Table <xref rid="Tab3" ref-type="table">3</xref>).</p><p id="Par24">Patients with posttraumatic amnesia (PTA) 24 h or less (<italic toggle="yes">n</italic> = 50) were analyzed separately. None of the correlations between NF-L levels and DTI metrics were significant in those patients even when divided into CT-positive and CT-negative subgroups (Supplementary table 1).</p></sec><sec id="Sec13"><title>OI controls</title><p id="Par25">There were 21 patients with orthopedic extracranial injuries in the control group. Median age for control subjects was 43 (IQR = 29) and most were male 12 (57.1%). The most common injury types were ankle fractures n = 12 (54.5%) and wrist fractures <italic toggle="yes">n</italic> = 2 (9.1%). Compared to the control group (median = 10.8, IQR = 6.8), the levels of NF-L were higher in the whole mTBI cohort (median = 14.28, IQR = 27.32, <italic toggle="yes">p</italic> = 0.038), in the subgroup of CT-positive patients (median = 31.37, IQR = 48.54, <italic toggle="yes">p</italic> &lt; 0.001), and in patients with incomplete recovery (median = 16.22, IQR = 40.97) (<italic toggle="yes">p</italic> = 0.01), but not in the CT-negative subgroup or in subjects with complete recovery (Table <xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec14"><title>Differences in NF-L levels in patients with mTBI</title><p id="Par26">The levels of NF-L were higher in CT-positive patients (median = 31.37, IQR = 48.54) compared with CT-negative patients (median = 10.42, IQR = 8.31) (<italic toggle="yes">p</italic> &lt; 0.001). Further, patients with incomplete recovery had higher NF-L levels (median = 16.22, IQR = 40.97) compared with patients with complete recovery (median = 11.16, IQR = 10.68) (<italic toggle="yes">p</italic> = 0.034) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Levels of NF-L in patients dichotomized based on CT findings (<bold>A</bold>) or their outcome (<bold>B</bold>). Computed tomography positive = CT-positive, computed tomography negative = CT-negative, Glasgow Outcome Scale Extended (GOSE) 8 = complete recovery, and Glasgow Outcome Scale Extended (GOSE) 1–7 = incomplete recovery</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12883_2023_3284_Fig2_HTML.jpg"/></fig></p></sec></sec><sec id="Sec15"><title>Discussion</title><p id="Par27">This prospective, observational study of patients with mTBI investigated the association between the admission levels of plasma NF-L with WM integrity, measured using DTI metrics from DW-MR images more than 3 months from the injury. Moreover, we also compared the admission levels of NF-L between the patients with mTBI and the OI control group. The main findings were as follows: (1) Significant negative correlations between the levels of NF-L and FA and significant positive correlations between the levels of NF-L and the other diffusivity measures were observed in the whole mTBI cohort, in patients with CT-positive findings, and in patients with incomplete recovery. (2) The admission levels of NF-L were significantly higher in the whole mTBI cohort, in patients with CT-positive findings, and in patients with incomplete recovery, compared to the control group. (3) Lower anisotropy and higher diffusivity measures were observed in CT-positive patients compared with patients without any CT findings. (4) Admission levels of NF-L were higher in CT-positive patients and in patients with incomplete recovery compared with CT-negative patients and patients with complete recovery respectively.</p><p id="Par28">NF-L protein has been extensively studied as a potential body fluid biomarker to investigate the ongoing axonal injury following TBI [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Several studies have shown that patients with mTBI or concussion had significantly higher levels of NF-L compared to healthy individuals or orthopedic controls, not only in the acute phase following the injury, but also in the subacute and chronic phases [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. After TBI, a significant increase in serum levels of NF-L has been observed, which persisted up to 10 – 12 days after injury [<xref ref-type="bibr" rid="CR46">46</xref>]. In addition, the admission levels, as well as the levels at several time-points, were correlated with the outcome of TBI [<xref ref-type="bibr" rid="CR46">46</xref>]. The levels of NF-L have been shown to be significantly elevated in contact sports athletes, for example, professional hockey players who suffered from symptoms after repetitive mTBI [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. It has also been reported that a single mild to moderate TBI may cause long-term neuroaxonal degeneration, which could be detected by NF-L as a surrogate marker [<xref ref-type="bibr" rid="CR32">32</xref>]. Of note, our research group lately reported that the levels of NF-L were able to differentiate patients with complete recovery from incomplete recovery, and favorable outcome from unfavorable outcome after mTBI. These results applied not only to the whole cohort, but also to patients with CT-positive mTBI, and the early levels of NF-L strongly correlated with outcome [<xref ref-type="bibr" rid="CR31">31</xref>]. Recent studies utilizing the admission and late samples reported that serum levels of NF-L were longitudinally associated with DTI estimates of DAI [<xref ref-type="bibr" rid="CR32">32</xref>]. Lower anisotropy and higher diffusivity measures may suggest compromised axonal integrity, demyelination, Wallerian degeneration and overall, might be an indication of axonal degeneration following mTBI [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. These findings are in accordance with previous studies in patients with TBI [<xref ref-type="bibr" rid="CR50">50</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. It has been reported that the elevated blood levels of NF-L at 6 months was significantly related to the metrics of microstructural injury on DTI [<xref ref-type="bibr" rid="CR54">54</xref>]. A recent multicenter prospective study of advanced fluid and imaging markers of axonal injury after moderate to severe TBI, BIO-AX-TBI [<xref ref-type="bibr" rid="CR55">55</xref>], demonstrated that the levels of plasma NF-L and DTI metrics are closely related in quantifying underlying axonal injury subacutely after TBI. In this study, microdialysate taken directly from damaged WM was found to contain very high levels of NF-L and this concentration of NF-L in microdialysis fluid significantly correlated with the levels of NF-L in plasma. Moreover, in the same study, the plasma levels of NF-L also correlated with histopathologically defined axonal injury within the WM, which was produced by an experimental injury model [<xref ref-type="bibr" rid="CR33">33</xref>]. Thus, the association between the plasma levels of NF-L and DTI metrics indicates that plasma NF-L measurement may reflect the damage of WM of the brain following TBI. The results of the present study are thus consistent with the aforementioned studies.</p><p id="Par29">The kinetics of NF-L as a blood biomarker has been recently explored by using several time points of sampling following TBI. These studies found that the peak of NF-L is between 10 days and 6 weeks following injury and that subacute levels strongly correlated with outcome [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. These results are in agreement with the concept that DAI is a slow, long-lasting process, as suggested by longitudinal imaging studies [<xref ref-type="bibr" rid="CR57">57</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. In the current study, only admission samples were used, since few patients with mTBI had samples available from later days. The observed correlation between the admission levels of NF-L and DTI metrics probably reflects the consequences of rapid regional axonal damage in those who show visible traumatic lesions, rather than reflecting the many secondary pathophysiological cascades contributing to subsequently evolving WM damage. This is supported by the fact that in CT-negative patients, significant correlations were not seen.</p><p id="Par30">A well-characterized, prospectively collected study population is a major strength of the study, but there are also limitations that need to be acknowledged. Although NF-L does not have sources outside the nervous system, it is known that trauma itself has at least indirect consequences on the brain. Thus, patients with orthopedic injuries were analyzed as controls in order to increase the reliability of the results. Besides the small sample size and a single-center study, other key limitations of this study are the timing of NF-L not being tight, the lack of data for NF-L levels at later timepoints after admission, and lack of DTI data at several time points to conduct longitudinal analyses. Given that NF-L is a slow marker [<xref ref-type="bibr" rid="CR62">62</xref>], i.e., the peak in blood comes days-weeks after injury, and that one-time DTI measures are unable to describe the temporal evolution of DAI [<xref ref-type="bibr" rid="CR63">63</xref>], this study is unable to shed light on the progression of such axonal injury. The main practical limitation, thus, is that this study is unable to show if NF-L at a later timepoint could predict incomplete recovery in patients who are CT-negative after an mTBI.</p><p id="Par31">For the critical interpretation of the study findings, it is also evident that the results were driven by patients with more severe injuries – especially those who had mass lesions or multiple contusions. To partially address this, CT-positive and CT-negative findings were analyzed separately, and significant findings were found only in the CT-positive subgroup. For the CT-negative subjects there was no significant correlation between the levels of NF-L and any of the diffusion metrics in either the complete or incomplete recovery subgroups. This suggests that the correlations observed in the incomplete recovery group, including both the CT-positive and the CT-negative, have been heavily influenced by the CT-positive group.</p><p id="Par32">Indeed, the severity of injury in our mTBI cohort was worse than in an average mTBI population typically seen in the ED, therefore it cannot be considered to represent cases with mTBI in general. It is important to know that we classified the patients to severity groups solely based on the admission GCS score. Classifying the severity of TBI using the lowest recorded GCS is one of the important limitations of this study. In our series, the mildest cases of mTBI were often discharged before the possibility to recruit and a relatively large percentage of our mTBI cohort showed traumatic intracranial CT abnormalities, consequently requiring hospital admission. Furthermore, even though all the recruited patients had GCS ≥ 13, categorized as mTBI, some patients had PTA for &gt; 24 h post injury, which is an indication of higher severity of TBI according to several classifications. PTA was assessed retrospectively using the Rivermead method [<xref ref-type="bibr" rid="CR64">64</xref>] at the outcome visit, whereas prospective evaluation is often considered to have higher reliability. Further analysis on patients with mTBI, also considering PTA, found that there was no significant correlation between the levels of NF-L and any of the diffusion metrics, irrespective of CT results. This shows that the significant results found are strongly driven by the cases at the severe end. Even though the variability of the GOSE assessment is another limitation, the same experienced blinded neurologist performed the assessments of all patients. These issues have been elaborated thoroughly in our previous publications. Functional outcome is much more complex than just complete or incomplete recovery as assessed with the GOSE and clinicians’ assessment of disability also vary and may be different from those of their patients [<xref ref-type="bibr" rid="CR65">65</xref>].</p><p id="Par33">Due to the logistics and the limited availability to scan patients, it was not possible to scan all subjects within a certain window of time after injury hence the difference in time from injury to imaging could be a limitation of this study. Acquisition of DW-MR images with a single shell and only one b0 is another shortcoming in this study. Acquiring multi-shell DW-MR data with several b0 images using advanced analysis approaches, such as neurite orientation dispersion and density imaging [<xref ref-type="bibr" rid="CR66">66</xref>], or using novel deep learning approaches suitable for single-shell DW-MRI [<xref ref-type="bibr" rid="CR67">67</xref>], might reveal signs of axonal injury not detectable in the current study. Furthermore, TBSS suffers from inherent limitations such as the inability to correctly differentiate complex WM fiber configurations and being susceptible to partial volume effects [<xref ref-type="bibr" rid="CR68">68</xref>].</p></sec><sec id="Sec16"><title>Conclusion</title><p id="Par34">The significant correlation between NF-L levels at admission and DTI measurements of DAI over more than 3 months suggests that plasma NF-L may associate with the presence of DAI during the acute phase of TBI and possibly help clinicians to recognize those patients who need more careful follow-up. This needs to be validated using several time-points of biomarker sampling, longitudinal DTI data, and larger cohorts. Large multicenter studies with adequate control groups, including patients with polytrauma as well as healthy controls, should be conducted before blood biomarker research findings can be translated into clinical practice. Moreover, future research should establish standard methods for quantification on different analytical platforms and define cut-off values for these blood biomarkers across different injury subtypes and age groups [<xref ref-type="bibr" rid="CR57">57</xref>–<xref ref-type="bibr" rid="CR59">59</xref>].</p></sec><sec sec-type="supplementary-material"><sec id="Sec17"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12883_2023_3284_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p><bold>Additional file 1: Supplementary Table 1.</bold> Correlation between the levels of neurofilament light and diffusion metrics in patients with mild traumatic brain injury with Glasgow Coma Scale of 13 and above and a duration of less than 24 hours of posttraumatic amnesia (PTA). FA = fractional anisotropy, MD = mean diffusivity, RD = radial diffusivity, AD = axial diffusivity.</p></caption></media></supplementary-material></p></sec></sec></body><back><fn-group><fn><p><bold>Publisher’s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Iftakher Hossain and Mehrbod Mohammadian have contributed equally to this work.</p></fn><fn><p>Kaj Blennow, Henrik Zetterberg and Jussi P. Posti have contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors thank our research nurses Patricia Bertenyi and Satu Honkala for their valuable contribution to this study.</p></ack><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>IH, JP, MM, and OT conceived and designed the study. JP, RT, H-RM, JT, and OT recruited the patients. JP, RT, H-RM, JT, IH, and OT designed the data collection at Turku University Hospital. MM mainly conducted the image and statistical analyses with contributions from H-RM, and IH. HZ, and KB supervised the biomarker analyses. IH drafted the manuscript with critical contributions from OT, JP, and MM. MG, TK, TR, JH, PH, H-RM, DM, VN, JT, KB, and HZ contributed to the revision of the manuscript. IH and JP take the responsibility for the paper as whole.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was partially funded by the European Commission under the 7th Framework Programme (FP7-270259-TBIcare), The Integra EANS Research Grant (IH), The Finnish Medical Foundation (IH), The Päivikki and Sakari Sohlberg Foundation (IH), The Paulo Foundation (IH), The Finnish Cultural Foundation (IH), University of Turku Graduate School funding (MM), Academy of Finland (#17379, JPP), Government’s Special Financial Transfer tied to academic research in Health Sciences (Finland) (JPP), Maire Taponen Foundation sr (JPP), personal grants from Emil Aaltonen Foundation sr (TR), and the Finnish Cultural Foundation (TR), and NIHR Research Professorship and the NIHR Cambridge BRC (PJH), NIHR Research UK (through a Senior Investigator Award and the Cambridge Biomedical Research Centre) (DKM), Academy of Medical Sciences / The Health Foundation Clinician Scientist Fellowship (VFN); Wallenberg Scholarship and grants from the Swedish and European Research Councils (HZ), and grants from the Swedish Research Council and the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986) (KB).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par35">The Ethics Committee of the Hospital District of Southwest Finland approved the study protocol (Decision 68/180/2011). All patients or their next of kin were informed about the study both verbally and in writing. Written informed consent was obtained from all participants or their next of kin. All methods were carried out in accordance with the Declaration of Helsinki of the World Medical Association.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par36">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par37">Iftakher Hossain has no financial disclosures; Mehrbod Mohammadian has no financial disclosures; Henna-Riikka Maanpää has no financial disclosures; Riikka S.K. Takala has no financial disclosures. RSKT has received speakers fee from Abbott, Fresenius-Kabi, Orion and UCB, conference funding from Pfizer and Steripolar and is stockholder of Orion; Olli Tenovuo has no financial disclosures; Mark van Gils has no financial disclosures; Peter J. Hutchinson is supported by the UK NIHR and Royal College of Surgeons of England; David K. Menon reports collaborative research or consultancy agreements with GlaxoSmithKline Ltd; Ornim Medical; Shire Medical; Calico Inc; Pfizer Ltd; Pressura Ltd; Glide Pharma Ltd; NeuroTraumaSciences LLC; Lantasman AB; Virginia F. Newcombe holds a grant with Roche Pharmaceuticals; Jussi Tallus has no financial disclosures; Jussi Hirvonen has no financial disclosures; Timo Roine has no financial disclosures; Timo Kurki has no financial disclosures; Henrik Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program; Kaj Blennow has served as a consultant or at advisory boards for Abcam, Axon, BioArctic, Biogen, JOMDD/Shimadzu. Julius Clinical, Lilly, MagQu, Novartis, Pharmatrophix, Prothena, Roche Diagnostics, and Siemens Healthineers, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program; Jussi P. Posti has no financial disclosures. JPP has received speaker’s fees from Orion corporation and Finnish Medical Association.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levin</surname><given-names>HS</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>RR</given-names></name></person-group><article-title>Diagnosis, prognosis, and clinical management of mild traumatic brain injury</article-title><source>Lancet Neurol</source><year>2015</year><volume>14</volume><fpage>506</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">25801547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(15)00002-2</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DH</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name></person-group><article-title>Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood</article-title><source>Nat Rev Neurol</source><year>2013</year><volume>9</volume><fpage>201</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">23399646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrneurol.2013.9</pub-id><pub-id pub-id-type="pmcid">PMC4513656</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giza</surname><given-names>CC</given-names></name><name name-style="western"><surname>Hovda</surname><given-names>DA</given-names></name></person-group><article-title>The new neurometabolic cascade of concussion</article-title><source>Neurosurgery</source><year>2014</year><volume>75</volume><fpage>S24</fpage><lpage>S33</lpage><pub-id pub-id-type="pmid">25232881</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1227/NEU.0000000000000505</pub-id><pub-id pub-id-type="pmcid">PMC4479139</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prins</surname><given-names>M</given-names></name><name name-style="western"><surname>Greco</surname><given-names>T</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>D</given-names></name><name name-style="western"><surname>Giza</surname><given-names>CC</given-names></name></person-group><article-title>The pathophysiology of traumatic brain injury at a glance</article-title><source>DMM Disease Models and Mechanisms</source><year>2013</year><volume>6</volume><fpage>1307</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">24046353</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1242/dmm.011585</pub-id><pub-id pub-id-type="pmcid">PMC3820255</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Tegner</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gustafsson</surname><given-names>B</given-names></name><name name-style="western"><surname>Gren</surname><given-names>M</given-names></name><name name-style="western"><surname>Ärlig</surname><given-names>J</given-names></name><name name-style="western"><surname>Olsson</surname><given-names>M</given-names></name><name name-style="western"><surname>Lehto</surname><given-names>N</given-names></name><name name-style="western"><surname>Engström</surname><given-names>Å</given-names></name><name name-style="western"><surname>Höglund</surname><given-names>K</given-names></name><name name-style="western"><surname>Portelius</surname><given-names>E</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name></person-group><article-title>Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury</article-title><source>JAMA Neurol</source><year>2016</year><volume>73</volume><fpage>1308</fpage><pub-id pub-id-type="pmid">27654934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2016.2038</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>VE</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>W</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DH</given-names></name></person-group><article-title>Axonal pathology in traumatic brain injury</article-title><source>Exp Neurol</source><year>2013</year><volume>246</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22285252</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.expneurol.2012.01.013</pub-id><pub-id pub-id-type="pmcid">PMC3979341</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Vieira, R. de C.A., Paiva, W.S., De Oliveira, D.V., Teixeira, M.J., De Andrade, A.F., and De Sousa, R.M.C. (2016). Diffuse axonal injury: Epidemiology, outcome and associated risk factors. Frontiers in Neurology 7.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2016.00178</pub-id><pub-id pub-id-type="pmcid">PMC5071911</pub-id><pub-id pub-id-type="pmid">27812349</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Topal</surname><given-names>NB</given-names></name><name name-style="western"><surname>Hakyemez</surname><given-names>B</given-names></name><name name-style="western"><surname>Erdogan</surname><given-names>C</given-names></name><name name-style="western"><surname>Bulut</surname><given-names>M</given-names></name><name name-style="western"><surname>Koksal</surname><given-names>O</given-names></name><name name-style="western"><surname>Akkose</surname><given-names>S</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>S</given-names></name><name name-style="western"><surname>Parlak</surname><given-names>M</given-names></name><name name-style="western"><surname>Ozguc</surname><given-names>H</given-names></name><name name-style="western"><surname>Korfali</surname><given-names>E</given-names></name></person-group><article-title>MR imaging in the detection of diffuse axonal injury with mild traumatic brain injury</article-title><source>Neurol Res</source><year>2008</year><volume>30</volume><fpage>974</fpage><lpage>978</lpage><pub-id pub-id-type="pmid">18691451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/016164108X323799</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Kou</surname><given-names>ZF</given-names></name><name name-style="western"><surname>Tian</surname><given-names>YQ</given-names></name></person-group><article-title>Diffuse axonal injury after traumatic cerebral microbleeds: An evaluation of imaging techniques</article-title><source>Neural Regen Res</source><year>2014</year><volume>9</volume><fpage>1222</fpage><lpage>1230</lpage><pub-id pub-id-type="pmid">25206786</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/1673-5374.135330</pub-id><pub-id pub-id-type="pmcid">PMC4146289</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amyot</surname><given-names>F</given-names></name><name name-style="western"><surname>Arciniegas</surname><given-names>DB</given-names></name><name name-style="western"><surname>Brazaitis</surname><given-names>MP</given-names></name><name name-style="western"><surname>Curley</surname><given-names>KC</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Gandjbakhche</surname><given-names>A</given-names></name><name name-style="western"><surname>Herscovitch</surname><given-names>P</given-names></name><name name-style="western"><surname>Hinds</surname><given-names>SR</given-names></name><name name-style="western"><surname>Manley</surname><given-names>GT</given-names></name><name name-style="western"><surname>Pacifico</surname><given-names>A</given-names></name><name name-style="western"><surname>Razumovsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Riley</surname><given-names>J</given-names></name><name name-style="western"><surname>Salzer</surname><given-names>W</given-names></name><name name-style="western"><surname>Shih</surname><given-names>R</given-names></name><name name-style="western"><surname>Smirniotopoulos</surname><given-names>JG</given-names></name><name name-style="western"><surname>Stocker</surname><given-names>D</given-names></name></person-group><article-title>A Review of the Effectiveness of Neuroimaging Modalities for the Detection of Traumatic Brain Injury</article-title><source>J Neurotrauma</source><year>2015</year><volume>32</volume><fpage>1693</fpage><lpage>1721</lpage><pub-id pub-id-type="pmid">26176603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2013.3306</pub-id><pub-id pub-id-type="pmcid">PMC4651019</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandstack</surname><given-names>N</given-names></name><name name-style="western"><surname>Kurki</surname><given-names>T</given-names></name><name name-style="western"><surname>Tenovuo</surname><given-names>O</given-names></name></person-group><article-title>Quantitative diffusion-tensor tractography of long association tracts in patients with traumatic brain injury without associated findings at routine MR imaging</article-title><source>Radiology</source><year>2013</year><volume>267</volume><fpage>231</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">23297328</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.12112570</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shenton</surname><given-names>ME</given-names></name><name name-style="western"><surname>Hamoda</surname><given-names>HM</given-names></name><name name-style="western"><surname>Schneiderman</surname><given-names>JS</given-names></name><name name-style="western"><surname>Bouix</surname><given-names>S</given-names></name><name name-style="western"><surname>Pasternak</surname><given-names>O</given-names></name><name name-style="western"><surname>Rathi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Vu</surname><given-names>MA</given-names></name><name name-style="western"><surname>Purohit</surname><given-names>MP</given-names></name><name name-style="western"><surname>Helmer</surname><given-names>K</given-names></name><name name-style="western"><surname>Koerte</surname><given-names>I</given-names></name><name name-style="western"><surname>Lin</surname><given-names>AP</given-names></name><name name-style="western"><surname>Westin</surname><given-names>CF</given-names></name><name name-style="western"><surname>Kikinis</surname><given-names>R</given-names></name><name name-style="western"><surname>Kubicki</surname><given-names>M</given-names></name><name name-style="western"><surname>Stern</surname><given-names>RA</given-names></name><name name-style="western"><surname>Zafonte</surname><given-names>R</given-names></name></person-group><article-title>A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury</article-title><source>Brain Imaging Behav</source><year>2012</year><volume>6</volume><fpage>137</fpage><lpage>192</lpage><pub-id pub-id-type="pmid">22438191</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11682-012-9156-5</pub-id><pub-id pub-id-type="pmcid">PMC3803157</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Eierud, C., Craddock, R.C., Fletcher, S., Aulakh, M., King-Casas, B., Kuehl, D., and Laconte, S.M. (2014). Neuroimaging after mild traumatic brain injury: Review and meta-analysis. NeuroImage: Clinical 4, 283–294.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nicl.2013.12.009</pub-id><pub-id pub-id-type="pmcid">PMC4107372</pub-id><pub-id pub-id-type="pmid">25061565</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maas</surname><given-names>AIR</given-names></name><name name-style="western"><surname>Menon</surname><given-names>DK</given-names></name><name name-style="western"><surname>Adelson</surname><given-names>PD</given-names></name><name name-style="western"><surname>Andelic</surname><given-names>N</given-names></name><name name-style="western"><surname>Bell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Belli</surname><given-names>A</given-names></name><name name-style="western"><surname>Bragge</surname><given-names>P</given-names></name><name name-style="western"><surname>Brazinova</surname><given-names>A</given-names></name><name name-style="western"><surname>Büki</surname><given-names>A</given-names></name><name name-style="western"><surname>Chesnut</surname><given-names>RM</given-names></name><name name-style="western"><surname>Citerio</surname><given-names>G</given-names></name><name name-style="western"><surname>Coburn</surname><given-names>M</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Crowder</surname><given-names>AT</given-names></name><name name-style="western"><surname>Czeiter</surname><given-names>E</given-names></name><name name-style="western"><surname>Czosnyka</surname><given-names>M</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Dreier</surname><given-names>JP</given-names></name><name name-style="western"><surname>Duhaime</surname><given-names>A-C</given-names></name><name name-style="western"><surname>Ercole</surname><given-names>A</given-names></name><name name-style="western"><surname>van Essen</surname><given-names>TA</given-names></name><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name><name name-style="western"><surname>Gao</surname><given-names>G</given-names></name><name name-style="western"><surname>Giacino</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonzalez-Lara</surname><given-names>LE</given-names></name><name name-style="western"><surname>Gruen</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>D</given-names></name><name name-style="western"><surname>Hartings</surname><given-names>JA</given-names></name><name name-style="western"><surname>Hill</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>J-Y</given-names></name><name name-style="western"><surname>Ketharanathan</surname><given-names>N</given-names></name><name name-style="western"><surname>Kompanje</surname><given-names>EJO</given-names></name><name name-style="western"><surname>Lanyon</surname><given-names>L</given-names></name><name name-style="western"><surname>Laureys</surname><given-names>S</given-names></name><name name-style="western"><surname>Lecky</surname><given-names>F</given-names></name><name name-style="western"><surname>Levin</surname><given-names>H</given-names></name><name name-style="western"><surname>Lingsma</surname><given-names>HF</given-names></name><name name-style="western"><surname>Maegele</surname><given-names>M</given-names></name><name name-style="western"><surname>Majdan</surname><given-names>M</given-names></name><name name-style="western"><surname>Manley</surname><given-names>G</given-names></name><name name-style="western"><surname>Marsteller</surname><given-names>J</given-names></name><name name-style="western"><surname>Mascia</surname><given-names>L</given-names></name><name name-style="western"><surname>McFadyen</surname><given-names>C</given-names></name><name name-style="western"><surname>Mondello</surname><given-names>S</given-names></name><name name-style="western"><surname>Newcombe</surname><given-names>V</given-names></name><name name-style="western"><surname>Palotie</surname><given-names>A</given-names></name><name name-style="western"><surname>Parizel</surname><given-names>PM</given-names></name><name name-style="western"><surname>Peul</surname><given-names>W</given-names></name><name name-style="western"><surname>Piercy</surname><given-names>J</given-names></name><name name-style="western"><surname>Polinder</surname><given-names>S</given-names></name><name name-style="western"><surname>Puybasset</surname><given-names>L</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>TE</given-names></name><name name-style="western"><surname>Rossaint</surname><given-names>R</given-names></name><name name-style="western"><surname>Smielewski</surname><given-names>P</given-names></name><name name-style="western"><surname>Söderberg</surname><given-names>J</given-names></name><name name-style="western"><surname>Stanworth</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Stein</surname><given-names>MB</given-names></name><name name-style="western"><surname>von Steinbüchel</surname><given-names>N</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>W</given-names></name><name name-style="western"><surname>Steyerberg</surname><given-names>EW</given-names></name><name name-style="western"><surname>Stocchetti</surname><given-names>N</given-names></name><name name-style="western"><surname>Synnot</surname><given-names>A</given-names></name><name name-style="western"><surname>Te Ao</surname><given-names>B</given-names></name><name name-style="western"><surname>Tenovuo</surname><given-names>O</given-names></name><name name-style="western"><surname>Theadom</surname><given-names>A</given-names></name><name name-style="western"><surname>Tibboel</surname><given-names>D</given-names></name><name name-style="western"><surname>Videtta</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>KKW</given-names></name><name name-style="western"><surname>Williams</surname><given-names>WH</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>L</given-names></name><name name-style="western"><surname>Yaffe</surname><given-names>K</given-names></name><name name-style="western"><surname>Participants</surname><given-names>InTBIR</given-names></name><name name-style="western"><surname>Investigators</surname><given-names>H</given-names></name><name name-style="western"><surname>Agnoletti</surname><given-names>V</given-names></name><name name-style="western"><surname>Allanson</surname><given-names>J</given-names></name><name name-style="western"><surname>Amrein</surname><given-names>K</given-names></name><name name-style="western"><surname>Andaluz</surname><given-names>N</given-names></name><name name-style="western"><surname>Anke</surname><given-names>A</given-names></name><name name-style="western"><surname>Antoni</surname><given-names>A</given-names></name><name name-style="western"><surname>van As</surname><given-names>AB</given-names></name><name name-style="western"><surname>Audibert</surname><given-names>G</given-names></name><name name-style="western"><surname>Azaševac</surname><given-names>A</given-names></name><name name-style="western"><surname>Azouvi</surname><given-names>P</given-names></name><name name-style="western"><surname>Azzolini</surname><given-names>ML</given-names></name><name name-style="western"><surname>Baciu</surname><given-names>C</given-names></name><name name-style="western"><surname>Badenes</surname><given-names>R</given-names></name><name name-style="western"><surname>Barlow</surname><given-names>KM</given-names></name><name name-style="western"><surname>Bartels</surname><given-names>R</given-names></name><name name-style="western"><surname>Bauerfeind</surname><given-names>U</given-names></name><name name-style="western"><surname>Beauchamp</surname><given-names>M</given-names></name><name name-style="western"><surname>Beer</surname><given-names>D</given-names></name><name name-style="western"><surname>Beer</surname><given-names>R</given-names></name><name name-style="western"><surname>Belda</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Bellander</surname><given-names>B-M</given-names></name><name name-style="western"><surname>Bellier</surname><given-names>R</given-names></name><name name-style="western"><surname>Benali</surname><given-names>H</given-names></name><name name-style="western"><surname>Benard</surname><given-names>T</given-names></name><name name-style="western"><surname>Beqiri</surname><given-names>V</given-names></name><name name-style="western"><surname>Beretta</surname><given-names>L</given-names></name><etal/></person-group><article-title>Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research</article-title><source>The Lancet Neurology</source><year>2017</year><volume>16</volume><fpage>987</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">29122524</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(17)30371-X</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basser</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mattiello</surname><given-names>J</given-names></name><name name-style="western"><surname>LeBihan</surname><given-names>D</given-names></name></person-group><article-title>MR diffusion tensor spectroscopy and imaging</article-title><source>Biophys J </source><year>1994</year><volume>66</volume><fpage>259</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">8130344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0006-3495(94)80775-1</pub-id><pub-id pub-id-type="pmcid">PMC1275686</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basser</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mattiello</surname><given-names>J</given-names></name><name name-style="western"><surname>LeBihan</surname><given-names>D</given-names></name></person-group><article-title>Estimation of the effective self-diffusion tensor from the NMR spin echo</article-title><source>J Magn Reson, Ser B</source><year>1994</year><volume>103</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">8019776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/jmrb.1994.1037</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Basser</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Mattiello</surname><given-names>J</given-names></name><name name-style="western"><surname>Lebihan</surname><given-names>D</given-names></name></person-group><article-title>Estimation of the Effective Self-Diffusion Tensor from the NMR Spin Echo</article-title><source>J Magn Reson, Ser B</source><year>1994</year><volume>103</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">8019776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/jmrb.1994.1037</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugiyama</surname><given-names>K</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name><name name-style="western"><surname>Oouchida</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suzukamo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Higano</surname><given-names>S</given-names></name><name name-style="western"><surname>Endo</surname><given-names>M</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name><name name-style="western"><surname>Shindo</surname><given-names>K</given-names></name><name name-style="western"><surname>Izumi</surname><given-names>S-I</given-names></name></person-group><article-title>Clinical Utility of Diffusion Tensor Imaging for Evaluating Patients with Diffuse Axonal Injury and Cognitive Disorders in the Chronic Stage</article-title><source>J Neurotrauma</source><year>2009</year><volume>26</volume><fpage>1879</fpage><lpage>1890</lpage><pub-id pub-id-type="pmid">19514848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2008.0839</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hashim</surname><given-names>E</given-names></name><name name-style="western"><surname>Caverzasi</surname><given-names>E</given-names></name><name name-style="western"><surname>Papinutto</surname><given-names>N</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>CE</given-names></name><name name-style="western"><surname>Jing</surname><given-names>R</given-names></name><name name-style="western"><surname>Charles</surname><given-names>O</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Lin</surname><given-names>A</given-names></name><name name-style="western"><surname>Graham</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Schweizer</surname><given-names>TA</given-names></name><name name-style="western"><surname>Bharatha</surname><given-names>A</given-names></name><name name-style="western"><surname>Cusimano</surname><given-names>MD</given-names></name></person-group><article-title>Investigating Microstructural Abnormalities and Neurocognition in Sub-Acute and Chronic Traumatic Brain Injury Patients with Normal-Appearing White Matter: A Preliminary Diffusion Tensor Imaging Study</article-title><source>Front Neurol</source><year>2017</year><volume>8</volume><fpage>97</fpage><pub-id pub-id-type="pmid">28373856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2017.00097</pub-id><pub-id pub-id-type="pmcid">PMC5357974</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">Yin, B., Li, D.D., Huang, H., Gu, C.H., Bai, G.H., Hu, L.X., Zhuang, J.F., and Zhang, M. (2019). Longitudinal changes in diffusion tensor imaging following mild traumatic brain injury and correlation with outcome. Frontiers in Neural Circuits 13.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fncir.2019.00028</pub-id><pub-id pub-id-type="pmcid">PMC6514143</pub-id><pub-id pub-id-type="pmid">31133818</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Roine, T., Mohammadian, M., Hirvonen, J., Kurki, T., Posti, J.P., Takala, R.S.K., Newcombe, V.F., Tallus, J., Katila, A.J., Maanpää, H.-R., Frantzen, J., Menon, D., and Tenovuo, O. (2022). Structural Brain Connectivity Correlates with Outcome in Mild Traumatic Brain Injury. Journal of neurotrauma .<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2021.0093</pub-id><pub-id pub-id-type="pmid">35018829</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dadas</surname><given-names>A</given-names></name><name name-style="western"><surname>Washington</surname><given-names>J</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Janigro</surname><given-names>D</given-names></name></person-group><article-title>Biomarkers in traumatic brain injury (TBI): a review</article-title><source>Neuropsychiatr Dis Treat</source><year>2018</year><volume>14</volume><fpage>2989</fpage><lpage>3000</lpage><pub-id pub-id-type="pmid">30510421</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/NDT.S125620</pub-id><pub-id pub-id-type="pmcid">PMC6231511</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>KK</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rubenstein</surname><given-names>R</given-names></name><name name-style="western"><surname>Tyndall</surname><given-names>JA</given-names></name><name name-style="western"><surname>Manley</surname><given-names>GT</given-names></name></person-group><article-title>An update on diagnostic and prognostic biomarkers for traumatic brain injury</article-title><source>Expert Rev Mol Diagn</source><year>2018</year><volume>18</volume><fpage>165</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">29338452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14737159.2018.1428089</pub-id><pub-id pub-id-type="pmcid">PMC6359936</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>KKW</given-names></name><name name-style="western"><surname>Papa</surname><given-names>L</given-names></name><name name-style="western"><surname>Sorani</surname><given-names>MD</given-names></name><name name-style="western"><surname>Yue</surname><given-names>JK</given-names></name><name name-style="western"><surname>Puccio</surname><given-names>AM</given-names></name><name name-style="western"><surname>McMahon</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Inoue</surname><given-names>T</given-names></name><name name-style="western"><surname>Yuh</surname><given-names>EL</given-names></name><name name-style="western"><surname>Lingsma</surname><given-names>HF</given-names></name><name name-style="western"><surname>Maas</surname><given-names>AIR</given-names></name><name name-style="western"><surname>Valadka</surname><given-names>AB</given-names></name><name name-style="western"><surname>Okonkwo</surname><given-names>DO</given-names></name><name name-style="western"><surname>Manley</surname><given-names>GT</given-names></name><name name-style="western"><surname>Investigators</surname><given-names>TRACK-TBI</given-names></name><name name-style="western"><surname>S.S., Cheong, M., Cooper, S.R., Dams-O’Connor, K., Gordon, W.A., Hricik, A.J., Menon, D.K., Mukherjee, P., Schnyer, D.M., Sinha, T.K., and Vassar, M.J. </surname></name></person-group><article-title>Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein</article-title><source>J Neurotrauma</source><year>2014</year><volume>31</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23865516</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2013.3040</pub-id><pub-id pub-id-type="pmcid">PMC3880090</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuhle</surname><given-names>J</given-names></name><name name-style="western"><surname>Barro</surname><given-names>C</given-names></name><name name-style="western"><surname>Andreasson</surname><given-names>U</given-names></name><name name-style="western"><surname>Derfuss</surname><given-names>T</given-names></name><name name-style="western"><surname>Lindberg</surname><given-names>R</given-names></name><name name-style="western"><surname>Sandelius</surname><given-names>Å</given-names></name><name name-style="western"><surname>Liman</surname><given-names>V</given-names></name><name name-style="western"><surname>Norgren</surname><given-names>N</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name></person-group><article-title>Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa</article-title><source>Clinical Chemistry and Laboratory Medicine (CCLM)</source><year>2016</year><volume>54</volume><fpage>1655</fpage><lpage>1661</lpage><pub-id pub-id-type="pmid">27071153</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/cclm-2015-1195</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>DH</given-names></name><name name-style="western"><surname>Rissin</surname><given-names>DM</given-names></name><name name-style="western"><surname>Kan</surname><given-names>CW</given-names></name><name name-style="western"><surname>Fournier</surname><given-names>DR</given-names></name><name name-style="western"><surname>Piech</surname><given-names>T</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>TG</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Fishburn</surname><given-names>MW</given-names></name><name name-style="western"><surname>Cabrera</surname><given-names>C</given-names></name><name name-style="western"><surname>Patel</surname><given-names>PP</given-names></name><name name-style="western"><surname>Frew</surname><given-names>E</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ferrell</surname><given-names>EP</given-names></name><name name-style="western"><surname>von Einem</surname><given-names>V</given-names></name><name name-style="western"><surname>McGuigan</surname><given-names>W</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>M</given-names></name><name name-style="western"><surname>Sayer</surname><given-names>H</given-names></name><name name-style="western"><surname>Vielsack</surname><given-names>C</given-names></name><name name-style="western"><surname>Duffy</surname><given-names>DC</given-names></name></person-group><article-title>The Simoa HD-1 Analyzer</article-title><source>J Lab Autom</source><year>2016</year><volume>21</volume><fpage>533</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">26077162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2211068215589580</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Shahim, P., Gren, M., Liman, V., Andreasson, U., Norgren, N., Tegner, Y., Mattsson, N., Andreasen, N., Öst, M., Zetterberg, H., Nellgård, B., and Blennow, K. (2016). Serum neurofilament light protein predicts clinical outcome in traumatic brain injury. Scientific Reports 6.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep36791</pub-id><pub-id pub-id-type="pmcid">PMC5098187</pub-id><pub-id pub-id-type="pmid">27819296</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Tegner</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>DH</given-names></name><name name-style="western"><surname>Randall</surname><given-names>J</given-names></name><name name-style="western"><surname>Skillbäck</surname><given-names>T</given-names></name><name name-style="western"><surname>Pazooki</surname><given-names>D</given-names></name><name name-style="western"><surname>Kallberg</surname><given-names>B</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name></person-group><article-title>Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players</article-title><source>JAMA Neurol</source><year>2014</year><volume>71</volume><fpage>684</fpage><pub-id pub-id-type="pmid">24627036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2014.367</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Ljungqvist, J., Zetterberg, H., Mitsis, M., Blennow, K., and Skoglund, T. (2017). Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study. Journal of Neurotrauma .<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2016.4496</pub-id><pub-id pub-id-type="pmid">27539721</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Tegner</surname><given-names>Y</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name></person-group><article-title>Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports</article-title><source>Neurology</source><year>2017</year><volume>88</volume><fpage>1788</fpage><lpage>1794</lpage><pub-id pub-id-type="pmid">28404801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000003912</pub-id><pub-id pub-id-type="pmcid">PMC5419986</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Hossain, I., Mohammadian, M., Takala, R.S.K., Tenovuo, O., Lagerstedt, L., Ala-Seppälä, H., Frantzén, J., van Gils, M., Hutchinson, P., Katila, A.J., Maanpää, H.-R., Menon, D.K., Newcombe, V.F., Tallus, J., Hrusovsky, K., Wilson, D.H., Blennow, K., Sanchez, J.-C., Zetterberg, H., and Posti, J.P. (2019). Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury. Journal of Neurotrauma , neu.2018.5952.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2018.5952</pub-id><pub-id pub-id-type="pmid">30489229</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Shahim, P., Politis, A., van der Merwe, A., Moore, B., Ekanayake, V., Lippa, S.M., Chou, Y.Y., Pham, D.L., Butman, J.A., Diaz-Arrastia, R., Zetterberg, H., Blennow, K., Gill, J.M., Brody, D.L., and Chan, L. (2020). Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI. Neurology .<pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009985</pub-id><pub-id pub-id-type="pmcid">PMC7455355</pub-id><pub-id pub-id-type="pmid">32641529</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Graham, N.S.N., Zimmerman, K.A., Moro, F., Heslegrave, A., Maillard, S.A., Bernini, A., Miroz, J.-P., Donat, C.K., Lopez, M.Y., Bourke, N., Jolly, A.E., Mallas, E.-J., Soreq, E., Wilson, M.H., Fatania, G., Roi, D., Patel, M.C., Garbero, E., Nattino, G., Baciu, C., Fainardi, E., Chieregato, A., Gradisek, P., Magnoni, S., Oddo, M., Zetterberg, H., Bertolini, G., and Sharp, D.J. (2021). Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury. Science Translational Medicine 13.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.abg9922</pub-id><pub-id pub-id-type="pmid">34586833</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawata</surname><given-names>K</given-names></name><name name-style="western"><surname>Steinfeldt</surname><given-names>JA</given-names></name><name name-style="western"><surname>Huibregtse</surname><given-names>ME</given-names></name><name name-style="western"><surname>Nowak</surname><given-names>MK</given-names></name><name name-style="western"><surname>Macy</surname><given-names>JT</given-names></name><name name-style="western"><surname>Kercher</surname><given-names>K</given-names></name><name name-style="western"><surname>Rettke</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Shin</surname><given-names>A</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ejima</surname><given-names>K</given-names></name><name name-style="western"><surname>Newman</surname><given-names>SD</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name></person-group><article-title>Association Between Proteomic Blood Biomarkers and DTI/NODDI Metrics in Adolescent Football Players: A Pilot Study</article-title><source>Front Neurol</source><year>2020</year><volume>11</volume><fpage>1417</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fneur.2020.581781</pub-id><pub-id pub-id-type="pmcid">PMC7701105</pub-id><pub-id pub-id-type="pmid">33304306</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Ashton, N.J., Suárez-Calvet, M., Karikari, T.K., Lantero-Rodriguez, J., Snellman, A., Sauer, M., Simrén, J., Minguillon, C., Fauria, K., Blennow, K., and Zetterberg, H. (2021). Effects of pre-analytical procedures on blood biomarkers for Alzheimer’s pathophysiology, glial activation, and neurodegeneration. Alzheimer’s &amp; dementia (Amsterdam, Netherlands) 13.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/dad2.12168</pub-id><pub-id pub-id-type="pmcid">PMC8171159</pub-id><pub-id pub-id-type="pmid">34124336</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>SP</given-names></name><name name-style="western"><surname>O’Neill</surname><given-names>B</given-names></name><name name-style="western"><surname>Haddon</surname><given-names>W</given-names></name><name name-style="western"><surname>Long</surname><given-names>WB</given-names></name></person-group><article-title>The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care</article-title><source>J Trauma</source><year>1974</year><volume>14</volume><fpage>187</fpage><lpage>196</lpage><pub-id pub-id-type="pmid">4814394</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="other">Marshall, L.F., Marshall, S.B., Klauber, M.R., Van Berkum Clark, M., Eisenberg, H., Jane, J.A., Luerssen, T.G., Marmarou, A., and Foulkes, M.A. (1992). The diagnosis of head injury requires a classification based on computed axial tomography. Journal of Neurotrauma .<pub-id pub-id-type="pmid">1588618</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>JTL</given-names></name><name name-style="western"><surname>Pettigrew</surname><given-names>LEL</given-names></name><name name-style="western"><surname>Teasdale</surname><given-names>GM</given-names></name></person-group><article-title>Structured Interviews for the Glasgow Outcome Scale and the Extended Glasgow Outcome Scale: Guidelines for Their Use</article-title><source>J Neurotrauma</source><year>1998</year><volume>15</volume><fpage>573</fpage><lpage>585</lpage><pub-id pub-id-type="pmid">9726257</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.1998.15.573</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leemans</surname><given-names>A</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DK</given-names></name></person-group><article-title>The B-matrix must be rotated when correcting for subject motion in DTI data</article-title><source>Magn Reson Med</source><year>2009</year><volume>61</volume><fpage>1336</fpage><lpage>1349</lpage><pub-id pub-id-type="pmid">19319973</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.21890</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Irfanoglu</surname><given-names>MO</given-names></name><name name-style="western"><surname>Walker</surname><given-names>L</given-names></name><name name-style="western"><surname>Sarlls</surname><given-names>J</given-names></name><name name-style="western"><surname>Marenco</surname><given-names>S</given-names></name><name name-style="western"><surname>Pierpaoli</surname><given-names>C</given-names></name></person-group><article-title>Effects of image distortions originating from susceptibility variations and concomitant fields on diffusion MRI tractography results</article-title><source>Neuroimage</source><year>2012</year><volume>61</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">22401760</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2012.02.054</pub-id><pub-id pub-id-type="pmcid">PMC3653420</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>AL</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lazar</surname><given-names>M</given-names></name><name name-style="western"><surname>Field</surname><given-names>AS</given-names></name></person-group><article-title>Diffusion Tensor Imaging of the Brain</article-title><source>Neurotherapeutics</source><year>2007</year><volume>4</volume><fpage>316</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">17599699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.nurt.2007.05.011</pub-id><pub-id pub-id-type="pmcid">PMC2041910</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>M</given-names></name><name name-style="western"><surname>Johansen-Berg</surname><given-names>H</given-names></name><name name-style="western"><surname>Rueckert</surname><given-names>D</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>TE</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>CE</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>KE</given-names></name><name name-style="western"><surname>Ciccarelli</surname><given-names>O</given-names></name><name name-style="western"><surname>Cader</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>PM</given-names></name><name name-style="western"><surname>Behrens</surname><given-names>TEJ</given-names></name></person-group><article-title>Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data</article-title><source>Neuroimage</source><year>2006</year><volume>31</volume><fpage>1487</fpage><lpage>1505</lpage><pub-id pub-id-type="pmid">16624579</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2006.02.024</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P, S., Y, T., DH, W., J, R., T, S., D, P., B, K., K, B., and H, Z. </surname></name></person-group><article-title>Blood biomarkers for brain injury in concussed professional ice hockey players</article-title><source>JAMA Neurol</source><year>2014</year><volume>71</volume><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="pmid">24627036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamaneurol.2014.367</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Tegner</surname><given-names>Y</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name></person-group><article-title>Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports</article-title><source>Neurology</source><year>2017</year><volume>88</volume><fpage>1788</fpage><pub-id pub-id-type="pmid">28404801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000003912</pub-id><pub-id pub-id-type="pmcid">PMC5419986</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Politis</surname><given-names>A</given-names></name><name name-style="western"><surname>van der Merwe</surname><given-names>A</given-names></name><name name-style="western"><surname>Moore</surname><given-names>B</given-names></name><name name-style="western"><surname>Chou</surname><given-names>Y-Y</given-names></name><name name-style="western"><surname>Pham</surname><given-names>DL</given-names></name><name name-style="western"><surname>Butman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Gill</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brody</surname><given-names>DL</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Chan</surname><given-names>L</given-names></name></person-group><article-title>Neurofilament light as a biomarker in traumatic braininjury</article-title><source>Neurology</source><year>2020</year><volume>95</volume><fpage>e610</fpage><pub-id pub-id-type="pmid">32641538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009983</pub-id><pub-id pub-id-type="pmcid">PMC7455357</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skillbäck</surname><given-names>T</given-names></name><name name-style="western"><surname>Farahmand</surname><given-names>B</given-names></name><name name-style="western"><surname>Bartlett</surname><given-names>JW</given-names></name><name name-style="western"><surname>Rosén</surname><given-names>C</given-names></name><name name-style="western"><surname>Mattsson</surname><given-names>N</given-names></name><name name-style="western"><surname>Nägga</surname><given-names>K</given-names></name><name name-style="western"><surname>Kilander</surname><given-names>L</given-names></name><name name-style="western"><surname>Religa</surname><given-names>D</given-names></name><name name-style="western"><surname>Wimo</surname><given-names>A</given-names></name><name name-style="western"><surname>Winblad</surname><given-names>B</given-names></name><name name-style="western"><surname>Rosengren</surname><given-names>L</given-names></name><name name-style="western"><surname>Schott</surname><given-names>JM</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Eriksdotter</surname><given-names>M</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name></person-group><article-title>CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival</article-title><source>Neurology</source><year>2014</year><volume>83</volume><fpage>1945</fpage><lpage>1953</lpage><pub-id pub-id-type="pmid">25339208</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000001015</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M, M., T, R., J, H., T, K., JP, P., AJ, K., RSK, T., J, T., HR, M., J, F., PJ, H., VF, N., DK, M., and O, T. </surname></name></person-group><article-title>Alterations in Microstructure and Local Fiber Orientation of White Matter Are Associated with Outcome after Mild Traumatic Brain Injury</article-title><source>J Neurotrauma</source><year>2020</year><volume>37</volume><fpage>2616</fpage><lpage>2623</lpage><pub-id pub-id-type="pmid">32689872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2020.7081</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sk</surname><given-names>S</given-names></name><name name-style="western"><surname>Sw</surname><given-names>S</given-names></name><name name-style="western"><surname>Wk</surname><given-names>J</given-names></name><name name-style="western"><surname>Sj</surname><given-names>L</given-names></name><name name-style="western"><surname>Ah</surname><given-names>C</given-names></name><name name-style="western"><surname>Ah</surname><given-names>N</given-names></name></person-group><article-title>Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia</article-title><source>Neuroimage</source><year>2003</year><volume>20</volume><fpage>1714</fpage><lpage>1722</lpage><pub-id pub-id-type="pmid">14642481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2003.07.005</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>C, B. </surname></name></person-group><article-title>The basis of anisotropic water diffusion in the nervous system - a technical review</article-title><source>NMR Biomed</source><year>2002</year><volume>15</volume><fpage>435</fpage><lpage>455</lpage><pub-id pub-id-type="pmid">12489094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nbm.782</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palacios</surname><given-names>EM</given-names></name><name name-style="western"><surname>Yuh</surname><given-names>EL</given-names></name><name name-style="western"><surname>Mac Donald</surname><given-names>CL</given-names></name><name name-style="western"><surname>Bourla</surname><given-names>I</given-names></name><name name-style="western"><surname>Wren-Jarvis</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><name name-style="western"><surname>Vassar</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Giacino</surname><given-names>JT</given-names></name><name name-style="western"><surname>Okonkwo</surname><given-names>DO</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>CS</given-names></name><name name-style="western"><surname>Stein</surname><given-names>MB</given-names></name><name name-style="western"><surname>Temkin</surname><given-names>N</given-names></name><name name-style="western"><surname>Mccrea</surname><given-names>MA</given-names></name><name name-style="western"><surname>Levin</surname><given-names>HS</given-names></name><name name-style="western"><surname>Markowitz</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Jain</surname><given-names>S</given-names></name><name name-style="western"><surname>Manley</surname><given-names>GT</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>P</given-names></name></person-group><article-title>Diffusion Tensor Imaging Reveals Elevated Diffusivity of White Matter Microstructure that Is Independently Associated with Long-Term Outcome after Mild Traumatic Brain Injury: A TRACK-TBI Study</article-title><source>J Neurotrauma</source><year>2022</year><volume>39</volume><fpage>1318</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">35579949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2021.0408</pub-id><pub-id pub-id-type="pmcid">PMC9529303</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">MF, K., T, S., BP, C., CJ, W., JA, S., and DM, L. (2007). White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain : a journal of neurology 130, 2508–2519.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awm216</pub-id><pub-id pub-id-type="pmid">17872928</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Kim, E., Yoo, R.E., Seong, M.Y., and Oh, B.M. (2022). A systematic review and data synthesis of longitudinal changes in white matter integrity after mild traumatic brain injury assessed by diffusion tensor imaging in adults. European Journal of Radiology 147.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejrad.2021.110117</pub-id><pub-id pub-id-type="pmid">34973540</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>G</given-names></name><name name-style="western"><surname>Liu</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Qian</surname><given-names>SW</given-names></name><name name-style="western"><surname>Yu</surname><given-names>LL</given-names></name></person-group><article-title>White Matter Changes in Posttraumatic Stress Disorder Following Mild Traumatic Brain Injury: A Prospective Longitudinal Diffusion Tensor Imaging Study</article-title><source>Chin Med J</source><year>2016</year><volume>129</volume><fpage>1091</fpage><pub-id pub-id-type="pmid">27098796</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0366-6999.180518</pub-id><pub-id pub-id-type="pmcid">PMC4852678</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Newcombe</surname><given-names>VFJ</given-names></name><name name-style="western"><surname>Ashton</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Posti</surname><given-names>JP</given-names></name><name name-style="western"><surname>Glocker</surname><given-names>B</given-names></name><name name-style="western"><surname>Manktelow</surname><given-names>A</given-names></name><name name-style="western"><surname>Chatfield</surname><given-names>DA</given-names></name><name name-style="western"><surname>Winzeck</surname><given-names>S</given-names></name><name name-style="western"><surname>Needham</surname><given-names>E</given-names></name><name name-style="western"><surname>Correia</surname><given-names>MM</given-names></name><name name-style="western"><surname>Williams</surname><given-names>GB</given-names></name><name name-style="western"><surname>Simrén</surname><given-names>J</given-names></name><name name-style="western"><surname>Takala</surname><given-names>RSK</given-names></name><name name-style="western"><surname>Katila</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Maanpää</surname><given-names>HR</given-names></name><name name-style="western"><surname>Tallus</surname><given-names>J</given-names></name><name name-style="western"><surname>Frantzén</surname><given-names>J</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Tenovuo</surname><given-names>O</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Menon</surname><given-names>DK</given-names></name></person-group><article-title>Post-acute blood biomarkers and disease progression in traumatic brain injury</article-title><source>Brain</source><year>2022</year><volume>145</volume><fpage>2064</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">35377407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/brain/awac126</pub-id><pub-id pub-id-type="pmcid">PMC9326940</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Graham, N.S.N., Zimmerman, K.A., Bertolini, G., Magnoni, S., Oddo, M., Zetterberg, H., Moro, F., Novelli, D., Heslegrave, A., Chieregato, A., Fainardi, E., Fleming, J.M., Garbero, E., Abed-Maillard, S., Gradisek, P., Bernini, A., and Sharp, D.J. (2020). Protocol: Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol. BMJ Open 10.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2020-042093</pub-id><pub-id pub-id-type="pmcid">PMC7656955</pub-id><pub-id pub-id-type="pmid">33172948</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahim</surname><given-names>P</given-names></name><name name-style="western"><surname>Politis</surname><given-names>A</given-names></name><name name-style="western"><surname>van der Merwe</surname><given-names>A</given-names></name><name name-style="western"><surname>Moore</surname><given-names>B</given-names></name><name name-style="western"><surname>Ekanayake</surname><given-names>V</given-names></name><name name-style="western"><surname>Lippa</surname><given-names>SM</given-names></name><name name-style="western"><surname>Chou</surname><given-names>Y-Y</given-names></name><name name-style="western"><surname>Pham</surname><given-names>DL</given-names></name><name name-style="western"><surname>Butman</surname><given-names>JA</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Zetterberg</surname><given-names>H</given-names></name><name name-style="western"><surname>Blennow</surname><given-names>K</given-names></name><name name-style="western"><surname>Gill</surname><given-names>JM</given-names></name><name name-style="western"><surname>Brody</surname><given-names>DL</given-names></name><name name-style="western"><surname>Chan</surname><given-names>L</given-names></name></person-group><article-title>Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 insubacute and chronic TBI</article-title><source>Neurology</source><year>2020</year><volume>95</volume><fpage>e623</fpage><pub-id pub-id-type="pmid">32641529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009985</pub-id><pub-id pub-id-type="pmcid">PMC7455355</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Moen, K.G., Håberg, A.K., Skandsen, T., Finnanger, T.G., and Vik, A. (2014). A Longitudinal magnetic resonance imaging study of the apparent diffusion coefficient values in corpus callosum during the first year after traumatic brain injury. Journal of Neurotrauma 31.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/neu.2013.3000</pub-id><pub-id pub-id-type="pmcid">PMC3880061</pub-id><pub-id pub-id-type="pmid">23837731</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Ljungqvist, J., Nilsson, D., Ljungberg, M., Esbjörnsson, E., Eriksson-Ritzén, C., and Skoglund, T. (2017). Longitudinal changes in diffusion tensor imaging parameters of the corpus callosum between 6 and 12 months after diffuse axonal injury. Brain Injury 31.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/02699052.2016.1256500</pub-id><pub-id pub-id-type="pmid">28128655</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Farbota, K.D., Bendlin, B.B., Alexander, A.L., Rowley, H.A., Dempsey, R.J., and Johnson, S.C. (2012). Longitudinal diffusion tensor imaging and neuropsychological correlates in traumatic brain injury patients. Frontiers in Human Neuroscience .<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnhum.2012.00160</pub-id><pub-id pub-id-type="pmcid">PMC3378081</pub-id><pub-id pub-id-type="pmid">22723773</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Macruz, F.B. de C., Feltrin, F.S., Zaninotto, A., Guirado, V.M. de P., Otaduy, M.C.G., Tsunemi, M.H., Nucci, M.P., Rimkus, C., Andrade, C.S., and Leite, C. da C. (2022). Longitudinal assessment of magnetization transfer ratio, brain volume, and cognitive functions in diffuse axonal injury. Brain and Behavior 12.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/brb3.2490</pub-id><pub-id pub-id-type="pmcid">PMC8933768</pub-id><pub-id pub-id-type="pmid">35103410</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="other">Newcombe, V.F.J., Correia, M.M., Ledig, C., Abate, M.G., Outtrim, J.G., Chatfield, D.O.R.I.S., Geeraerts, T., Manktelow, A.E., Garyfallidis, E., Pickard, J.D., Sahakian, B.J., Hutchinson, P.J.A., Rueckert, D., Coles, J.P., Williams, G.B., and Menon, D.K. (2016). Dynamic Changes in White Matter Abnormalities Correlate with Late Improvement and Deterioration Following TBI: A Diffusion Tensor Imaging Study. Neurorehabilitation and Neural Repair 30.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1545968315584004</pub-id><pub-id pub-id-type="pmid">25921349</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">P, S., A, P., A, van der M., B, M., YY, C., DL, P., JA, B., R, D.-A., JM, G., DL, B., H, Z., K, B., and L, C. (2020). Neurofilament light as a biomarker in traumatic brain injury. Neurology 95, e610–e622.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000009983</pub-id><pub-id pub-id-type="pmcid">PMC7455357</pub-id><pub-id pub-id-type="pmid">32641538</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niogi</surname><given-names>SN</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>P</given-names></name></person-group><article-title>Diffusion tensor imaging of mild traumatic brain injury</article-title><source>J Head Trauma Rehabil</source><year>2010</year><volume>25</volume><fpage>241</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">20611043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/HTR.0b013e3181e52c2a</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>NS</given-names></name><name name-style="western"><surname>Crawford</surname><given-names>S</given-names></name><name name-style="western"><surname>Wenden</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Moss</surname><given-names>NEG</given-names></name><name name-style="western"><surname>Wade</surname><given-names>DT</given-names></name><name name-style="western"><surname>Caldwell</surname><given-names>FE</given-names></name></person-group><article-title>Measurement of post-traumatic amnesia: how reliable is it?</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1997</year><volume>62</volume><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">9010398</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jnnp.62.1.38</pub-id><pub-id pub-id-type="pmcid">PMC486693</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tenovuo</surname><given-names>O</given-names></name><name name-style="western"><surname>Diaz-Arrastia</surname><given-names>R</given-names></name><name name-style="western"><surname>Goldstein</surname><given-names>LE</given-names></name><name name-style="western"><surname>Sharp</surname><given-names>DJ</given-names></name><name name-style="western"><surname>van der Naalt</surname><given-names>J</given-names></name><name name-style="western"><surname>Zasler</surname><given-names>ND</given-names></name></person-group><article-title>Assessing the Severity of Traumatic Brain Injury—Time for a Change?</article-title><source>J Clin Med</source><year>2021</year><volume>10</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm10010148</pub-id><pub-id pub-id-type="pmcid">PMC7795933</pub-id><pub-id pub-id-type="pmid">33406786</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>T</given-names></name><name name-style="western"><surname>Wheeler-Kingshott</surname><given-names>CA</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>DC</given-names></name></person-group><article-title>NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain</article-title><source>Neuroimage</source><year>2012</year><volume>61</volume><fpage>1000</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">22484410</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2012.03.072</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wasserthal</surname><given-names>J</given-names></name><name name-style="western"><surname>Neher</surname><given-names>P</given-names></name><name name-style="western"><surname>Maier-Hein</surname><given-names>KH</given-names></name></person-group><article-title>TractSeg - Fast and accurate white matter tract segmentation</article-title><source>Neuroimage</source><year>2018</year><volume>183</volume><fpage>239</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">30086412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuroimage.2018.07.070</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bach</surname><given-names>M</given-names></name><name name-style="western"><surname>Fritzsche</surname><given-names>KH</given-names></name><name name-style="western"><surname>Stieltjes</surname><given-names>B</given-names></name><name name-style="western"><surname>Laun</surname><given-names>FB</given-names></name></person-group><article-title>Investigation of resolution effects using a specialized diffusion tensor phantom</article-title><source>Magn Reson Med</source><year>2014</year><volume>71</volume><fpage>1108</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">23657980</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/mrm.24774</pub-id></element-citation></ref></ref-list></back></article>